Sandbox: HS: Difference between revisions

Jump to navigation Jump to search
 
(82 intermediate revisions by 2 users not shown)
Line 4: Line 4:


==Differential diagnosis==
==Differential diagnosis==
 
span style="font-size:85%">'''Abbreviations:'''
AP= Anteroposterior, CXR= [[Chest X-ray]], CT= [[Computed tomography]], ABG= [[Arterial blood gas]], V/Q= [[Ventilation/perfusion scan]] , EKG= [[Electrocardiogram]], COPD= [[Chronic obstructive pulmonary disease]], BNP= [[Brain natriuretic peptide]], DVT= [[Deep vein thrombosis]], HRCT= [[High Resolution CT]], IgE= [[Immunoglobulin E]]</span> 
{| align="center"
|-
|
[[Seizure|<nowiki/>]]
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
! colspan="2" rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Causes of cyanosis
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
! colspan="2" rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Cyanosis
| colspan="6" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Clinical manifestations/association'''
! colspan="3" rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Diagnosis
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Additional
findings
|-
| colspan="3" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Symptoms'''
! colspan="3" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Signs
|-
! style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
! style="background:#4479BA; color: #FFFFFF;" align="center" |Central
! style="background:#4479BA; color: #FFFFFF;" align="center" |Dyspnea
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Fever
! style="background:#4479BA; color: #FFFFFF;" align="center" |Chest pain
! style="background:#4479BA; color: #FFFFFF;" align="center" |Clubbing
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral edema
! style="background:#4479BA; color: #FFFFFF;" align="center" |Auscultation
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Lab Findings
! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard
|-
! rowspan="13" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Respiratory
! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Airway
disorder
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Severe [[croup]]<ref name="Cherry20082">{{cite journal|last1=Cherry|first1=James D.|title=Croup|journal=New England Journal of Medicine|volume=358|issue=4|year=2008|pages=384–391|issn=0028-4793|doi=10.1056/NEJMcp072022}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Audible [[stridor]] at rest
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Lymphocytosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |AP Neck X ray for soft tissues:
*[[Steeple sign]]
Lateral neck X ray:
*Distended [[hypopharynx]] during [[inspiration]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Croupy cough and [[stridor]]
*Intercostal, subcostal retractions
|-
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Epiglottitis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Stridor]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Leukocytosis]] with [[neutrophilia]]
*Blood cultures
*Throat culture in intubated patients
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Lateral neck X ray
*[[Thumbprint sign]] (swollen epiglottis)
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Laryngoscopy]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Sore Throat]]
*[[Dysphagia]]
*[[Odynophagia]]
*Muffled voice


<span style="font-size:85%">'''Abbreviations:'''
<span style="font-size:85%">'''Abbreviations:'''
COPD= [[Chronic obstructive pulmonary disease]],</span>  
AP= Anteroposterior, CXR= [[Chest X-ray]], CT= [[Computed tomography]], ABG= [[Arterial blood gas]], V/Q= [[Ventilation/perfusion scan]] , EKG= [[Electrocardiogram]], COPD= [[Chronic obstructive pulmonary disease]], BNP= [[Brain natriuretic peptide]], DVT= [[Deep vein thrombosis]], HRCT= [[High Resolution CT]], IgE= [[Immunoglobulin E]]</span>
 
{| align="center"
{| align="center"
|-
|-
|
|
[[Seizure|<nowiki/>]]
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
! colspan="2" rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Causes of cyanosis
! colspan="2" rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Causes of cyanosis
Line 36: Line 110:
! style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard
! style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard
|-
|-
! rowspan="15" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Respiratory
! rowspan="13" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Respiratory
! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Airway
! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Airway
disorder
disorder
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Croup]]
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Severe [[croup]]<ref name="Cherry20082">{{cite journal|last1=Cherry|first1=James D.|title=Croup|journal=New England Journal of Medicine|volume=358|issue=4|year=2008|pages=384–391|issn=0028-4793|doi=10.1056/NEJMcp072022}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Audible [[stridor]] at rest
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
*[[Lymphocytosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |AP Neck X ray for soft tissues:
*[[Steeple sign]]
Lateral neck X ray:
*Distended [[hypopharynx]] during [[inspiration]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Croupy cough and [[stridor]]
*Intercostal, subcostal retractions
|-
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Epiglottitis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Stridor]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Leukocytosis]] with [[neutrophilia]]
*Blood cultures
*Throat culture in intubated patients
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Lateral neck X ray
*[[Thumbprint sign]] (swollen epiglottis)
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Laryngoscopy]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Sore Throat]]
*[[Dysphagia]]
*[[Odynophagia]]
*Muffled voice
*Drooling
|-
|-
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Epiglottitis]]
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Foreign body aspiration]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*Decreased breath sounds
*[[Wheezing]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[ABG|ABGs]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CXR
*Hyperinflation (children)
*[[Atelectasis]] (adults)
*Objects
[[CT scan]]
*Foreign body
*Entrapment with [[edema]] or [[granulation tissue]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Bronchoscopy]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Complications:
*Inflammation
*[[Mediastinitis]]
*Local [[emphysema]]
*[[Atelectasis]]
*Cyanosis
|-
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Bacterial tracheitis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
*Inspiratory [[stridor]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Blood cultures]]
*[[Gram stain]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Lateral neck X ray
*Confusing
*[[Steeple sign]]
*Irregular tracheal margin
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Laryngotracheo[[Bronchoscopy|-bronchoscopy]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Brassy cough
*Retractions
*No drooling
*Hoarseness
|-
! style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
! style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
! style="background:#4479BA; color: #FFFFFF;" align="center" |Central
! style="background:#4479BA; color: #FFFFFF;" align="center" |Dyspnea
! style="background:#4479BA; color: #FFFFFF;" align="center" |Fever
! style="background:#4479BA; color: #FFFFFF;" align="center" |Chest pain
! style="background:#4479BA; color: #FFFFFF;" align="center" |Clubbing
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral edema
! style="background:#4479BA; color: #FFFFFF;" align="center" |Auscultation
! style="background:#4479BA; color: #FFFFFF;" align="center" |Lab Findings
! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
|-
! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Parenchymal
disorder
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pneumonia]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
*Reduced breath sounds
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
*Rales, [[crackles]], wheeze
*[[Pleural friction rub]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[ABG|ABGs]]
*Leukocytosis
*Pancytopenia
*[[Hyponatremia]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*CXR
*CT chest
*Bronchoscopy
*Sputum culture and gram stain
*Blood cultures
*Urine antigen
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Tachycardia]]
*[[Bradycardia]]  ([[Legionella]])
*[[CURB-65]]
|-
|-
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Foreign body aspiration
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Asthma]]
(Late)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ in [[interstitial lung disease]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*End expiratory [[wheeze]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*Absent [[wheeze]] and breath sounds in severe form
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
*[[ABG]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
*[[Eosinophilia]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
*[[IgE]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CXR
*to rule out other diagnosis
*complications like pneumonia, [[atelactasis]]
HRCT
*[[Allergic bronchopulmonary aspergillosis]]
*[[Bronchiectasis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Reversible obstructive disease
*[[Peak expiratory flow]] measurement is easy and very helpful
*[[GERD]] is a cause in case of refractory asthma.
*Triad of [[asthma]], [[nasal polyps]] and [[rash]] is indicative of [[Aspirin desensitization|aspirin sensitivity]].
|-
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cystic fibrosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |when infected
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Wheeze]] or crackles
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Sputum stain and culture
*[[Sweat test]]
*Genetic test for [[CFTR (gene)]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CXR
*Hyperinflation
*Peribronchial thickening
*Nodules
*[[Bronchiectasis]]
HRCT for detecting lung changes
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Sweat test
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Usually present since birth
*Recurrent pneumonia
*Recurrent wheezing
*Recurrent sinusitis
*Gastrointestinal manifestations
**[[Meconium ileus]]
**[[Pancreatic insufficiency]]
|-
|-
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Airway trauma
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[COPD]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
(Severe [[emphysema]])
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
*Reduced breath sounds
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
*Prolonged  expiration
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ±
*[[Wheeze]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
*Inspiratory [[crackles]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Hematocrit]]
*[[ABG]]
*Sputum staining and culture
*[[Alpha 1-antitrypsin deficiency laboratory tests|Alpha 1-antitrypsin test]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CXR
*Elongated heart
*Flattening of diaphragms
*Prominent hilar vasculature
HRCT
*Bullae
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*HRCT
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Pulmonary hypertension]]
*[[Right heart failure]]
|-
|-
! style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
! style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
Line 109: Line 361:
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
|-
|-
! rowspan="7" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Parenchymal
! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Pulmonary vascular disorders
disorder
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Massive [[pulmonary embolism]]
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pulmonary embolism]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*Reduced breath sounds
*Rales, crackles
*Loud [[P2]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[ABG|ABGs]]
*D-dimer
*EKG
*[[BNP]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*CXR
*V/Q scan
*Spiral [[CT pulmonary angiogram]]
*Venous ultrasound for [[DVT]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Spiral [[CT pulmonary angiogram]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Tachycardia]]
*[[Shock]]
*[[Pulmonary hypertension]] can occur
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pulmonary arterio-venous malformation]]<ref name="pmid119300212">{{cite journal |vauthors=Khurshid I, Downie GH |title=Pulmonary arteriovenous malformation |journal=Postgrad Med J |volume=78 |issue=918 |pages=191–7 |year=2002 |pmid=11930021 |pmc=1742331 |doi= |url=}}</ref><ref name="pmid195683982">{{cite journal |vauthors=Doshi HM, Robinson S, Chalhoub T, Jack S, Denison A, Gibson G |title=Massive spontaneous hemothorax during the immediate postpartum period |journal=Tex Heart Inst J |volume=36 |issue=3 |pages=247–9 |year=2009 |pmid=19568398 |pmc=2696501 |doi= |url=}}</ref><ref name="pmid15541322">{{cite journal |vauthors=Chanatry BJ |title=Acute hemothorax owing to pulmonary arteriovenous malformation in pregnancy |journal=Anesth. Analg. |volume=74 |issue=4 |pages=613–5 |year=1992 |pmid=1554132 |doi= |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*Pulmonary bruit
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* ABGs
*[[CBC]]
* D-dimer
*[[ABG]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CXR
*Round/oval mass
**lobulated
**well defined
*Connecting vessel in hilum
*[[Hemothorax]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* CXR
*[[Pulmonary angiography]]
* V/Q scan
*Contrast [[echocardiography]]
* Spiral [[CT pulmonary angiogram]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Classic triad of [[dyspnea on exertion]], [[cyanosis]] and [[clubbing]]
* Dyspnea
*[[Cerebral arteriovenous malformation]]
* Tachycardia
*[[Pregnancy]] can increase the size
* Pleuretic chest pain
|-
|-
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pneumonia]]
! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Chest <br> wall disorders
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Flail chest]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* ABGs
* Leukocytosis
* Pancytopenia
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*CXR
*CT chest
*Bronchoscopy
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Shortness of breath
* Cough
|-
|-
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Asthma]]  
! rowspan="13" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Cardiovascular
(Late)
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pneumothorax]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*Decreased breath sounds
*[[Wheezing]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |
| style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
| style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
| style="background:#4479BA; color: #FFFFFF;" align="center" |Central
| style="background:#4479BA; color: #FFFFFF;" align="center" |Dyspnea
| style="background:#4479BA; color: #FFFFFF;" align="center" |Fever
| style="background:#4479BA; color: #FFFFFF;" align="center" |Chest pain
| style="background:#4479BA; color: #FFFFFF;" align="center" |Clubbing
| colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral edema
| style="background:#4479BA; color: #FFFFFF;" align="center" |Auscultation
| style="background:#4479BA; color: #FFFFFF;" align="center" |Lab Findings
| style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging
| style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard
| style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |
[[Atrioventricular canal defect (patient information)|Atrioventricular canal defect]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
 
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CBC]]
* [[EKG]]
* [[Pulse oximetry]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]] (Cardiac enlargement, Increased pulmonary vascular markings)
*[[Echocardiography]]
*[[MRI]]
*[[Cardiac catheterization]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
** [[Echocardiography]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cystic fibrosis]]
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Ebstein anomaly]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ±
* [[CBC]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ±
* [[EKG]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
* [[Pulse oximetry]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]] (Cardiac enlargement, decreased pulmonary vascular markings)
* [[Echocardiography]]
* [[MRI]]
* [[Cardiac catheterization]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Echocardiography]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Tetralogy of Fallot]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + (systolic)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
* [[CBC]]
* [[EKG]]
* [[Pulse oximetry]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[CXR]] (Boot shaped heart, decreased pulmonary vascular markings)
*[[Echocardiography]]
*[[MRI]]
*[[Cardiac catheterization]]
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Echocardiography]]
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |COPD
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |
([[Emphysema]])
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pulmonic stenosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + (systolic)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
* [[CBC]]
* [[EKG]]
* [[Pulse oximetry]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]] (Cardiac enlargement, decreased pulmonary vascular markings)
* [[Echocardiography]]
* [[MRI]]
* [[Cardiac catheterization]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Echocardiography]]
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Total anomalous pulmonary venous drainage|Total anomalous pulmonary]]  [[Total anomalous pulmonary venous drainage|venous connection]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | <nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + (Systolic)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
* [[CBC]]
* [[EKG]]
* [[Pulse oximetry]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]] (normal heart size and venous congestion but in patients without obstruction have cardiomegaly and increased pulmonary blood flow.)
* [[Echocardiography]]
* [[MRI]]
* [[Cardiac catheterization]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Echocardiography]]
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Transposition of the great vessels]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
* [[CBC]]
* [[EKG]]
* [[Pulse oximetry]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]] (Cardiac enlargement, increased pulmonary vascular markings)
* [[Echocardiography]]
* [[MRI]]
* [[Cardiac catheterization]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Echocardiography]]
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Empyema]]
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Truncus arteriosus]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |sys/±dias
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ±
* [[CBC]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | <nowiki>+</nowiki>
* [[EKG]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
* [[Pulse oximetry]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Thoracentesis]]
* [[CXR]] (Cardiac enlargement, increased pulmonary vascular markings)
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Chest X-ray]]
* Pleural opacity


* Localization of effusion
* [[Echocardiography]]
* [[MRI]]
* [[Cardiac catheterization]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Physical examination
* [[Echocardiography]]
* Crackles
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Egophony]]
* Increased [[tactile fremitus]]
|-
|-
! rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |
! style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
! style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
! style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
! style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
Line 234: Line 651:
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
|-
|-
! rowspan="3" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Chest
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Heart failure]]
wall
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 
disorders
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Flail chest]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
([[S3]])
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
* [[CBC]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
* Complete metabolic profile
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ±
* Cardiac enzymes
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
* BNP
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
* [[Thyroid function tests|Thyroid profile]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
* [[Renal function tests]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* EKG
* [[Exercise stress testing|Exercise stress test]]
* [[ABG|ABG's]]
* [[Lipid profile]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* CXR
** Increase in heart size compared to the old film.
** Pleural fluid
** Interstitial edema
* Echocardiography
* Angiography
* Cardiac MRI
* Nuclear imaging
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Echocardiography]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Endomyocardial biopsy can be used when a specific diagnosis is suspected that would influence therapy in heart failure patients.
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pneumothorax]]
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Valvular heart disease]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |  
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CBC]]
* [[Complete metabolic profile]]
* [[Cardiac enzymes]]
* [[BNP]]
* [[Thyroid profile]]
* [[Renal function tests]]
* [[EKG]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]]
** To assess pulomary congestion or other lung pathology.
* [[Echocardiography]]
* [[Doppler echocardiography]]
* [[Angiography]]
** To assess the need for concomitant coronary artery bypass surgery in elderly people.
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Echocardiography]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hemothorax]]
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Myocardial infarction]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |  
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CBC
* [[Complete metabolic profile
* [[Cardiac enzymes
* [[BNP]]
* [[Thyroid profile]]
* [[Renal function tests]]
* [[EKG]]
* [[Lipid profile]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]]
** Normal or may show signs of [[CHF]]
* [[Echocardiography]]
* [[Angiography]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
! rowspan="14" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Cardiovascular
! colspan="2" rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Central Nervous system
! rowspan="10" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Congenital heart diseases|Congenital]]
[[Congenital heart diseases|heart diseases]]
! style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
! style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
! style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
! style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
Line 297: Line 755:
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
|-
|-
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Methemoglobinemia]]
[[Atrioventricular canal defect (patient information)|Atrioventricular canal defect]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CBC]]
* [[Peripheral smear]]
* [[Complete metabolic profile]]
* [[Hemoglobin electrophoresis]]
* [[Serum nitrite levels]]
* [[Pulse oximetry]]
* [[ABG's]]
* [[Drug screen]]
* [[LDH]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]]
* [[EKG]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Family history of methemoglobinemia or glucose-6-phosphate dehydrogenase (G6PD) deficiency is important to determine.
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Polycythemia]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
Line 308: Line 790:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CBC]]
** Raised all cell lines in primary and only raised erythrocytes in secondary polycythemia
* [[Pulse oximetry]]
* [[Erythropoietin levels (EPO)]]
* [[Ferritin levels]]
* [[ABG's]]
* [[Increased leukocyte alkaline phosphatase]]
* [[B12 levels]]
* [[JAK 2 mutation]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]]
* [[EKG]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Tenderness in the sternum may indicate transformation to acute myeloid leukemia and should be properly investigated.
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Ebstein anomaly]]
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hypoplastic left heart syndrome]]
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pulmonary atresia]]
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Tetralogy of Fallot]]
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pulmonic stenosis]]
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Total anomalous pulmonary venous drainage|Total anomalous pulmonary]]  [[Total anomalous pulmonary venous drainage|venous drainage]]
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Transposition of the great vessels]]
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Truncus arteriosus]]
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
! rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |
! style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
! style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
! style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
! style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
Line 439: Line 819:
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Heart failure]]
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Breath holding spells
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
{| class="wikitable"
|✔
|}
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* No confirmatory study
* [[CBC]]
* [[Serum ferritin]]
* [[Blood lead level]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* video-EEG monitoring can be use in non diagnostic cases.
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Cyanotic breath-holding spells most commonly occur around 1 year of age with a range of six months to four years.
* Iron deficiency anemia is more prevalent in children with breath-holding spells. 
|-
! colspan="2" rowspan="3" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Miscellaneous
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Shock]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + (septic shock)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + (Cardiogenic shock)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Complete metabolic profile]]
* [[CBC]]
* [[Cardiac enzymes]]
* [[ABG's]]
* [[Lactate]]
* [[BNP]]
* [[Renal function tests]]
* [[Coagulation studies and D-dimer level]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Echocardiography]]
* [[Chest radiography]]
* [[Angiography]]
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Valvular heart disease]]
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Smoke inhalation
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*  [[CBC]]
[[Electrolytes]]
[[BUN and CR]],
[[Lactate levels]]
[[Toxicology screen]]
[[CO-oximetry]] 
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
** [[CXR]]
** [[ECG]]
** [[Serial cardiac enzymes]] (in patients with chest pain)\
** [[Pulmonary function testing]]
** [[Direct laryngoscopy and fiberoptic bronchoscopy]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* CO toxicity should be suspected in any patient who presents following smoke inhalation unless co-oximetry shows normal carboxyhemoglobin.
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Myocardial infarction]]
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Cold exposure
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
Line 477: Line 909:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Fingerstick glucose]] (Hyperglycemia)
*[[Electrocardiogram]] (ECG) may show J wave, sinus bradycardia and prolongation of all ECG intervals.
*[[Serum electrolytes]] (including potassium and calcium)
*[[BUN and creatinine]]
*[[Serum hemoglobin]], [[white blood cell]], and [[platelet]] counts ( Raised HCT due to volume contraction)
*[[Coagulation profile]] acidosis)
*[[Creatine kinase]] (Rhabdomylosis)
*[[Arterial blood gas]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* CXR
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* '''Mild hypothermia''': core temperature 32 to 35°C ; patient presents with confusion, tachycardia, and increased shivering.
*'''Moderate hypothermia''': 28 to 32°C  patient presents with lethargy, bradycardia and arrhythmia and decreased shivering.
*'''Severe hypothermia''': below 28°C patient presents with coma, hypotension, arrhythmia, pulmonary edema, and rigidity.
|-
|}
|}
{| align="center"
|-
|-
! colspan="2" rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Hematologic
|
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Methemoglobinemia]]
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! colspan="3" rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Causes of cyanosis
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! colspan="2" rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Cyanosis
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| colspan="6" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Clinical manifestations/association'''
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! colspan="3" rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Diagnosis
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Additional
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
findings
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Polycythemia]]
| colspan="3" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Symptoms'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! colspan="3" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Signs
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
! colspan="2" rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Central Nervous system
! style="background:#4479BA; color: #FFFFFF;" align="center" |
! style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
! style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
! style="background:#4479BA; color: #FFFFFF;" align="center" |Central
! style="background:#4479BA; color: #FFFFFF;" align="center" |Central
! style="background:#4479BA; color: #FFFFFF;" align="center" |Dyspnea
! style="background:#4479BA; color: #FFFFFF;" align="center" |Dyspnea
! style="background:#4479BA; color: #FFFFFF;" align="center" |Fever
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Fever  
! style="background:#4479BA; color: #FFFFFF;" align="center" |Chest pain
! style="background:#4479BA; color: #FFFFFF;" align="center" |Chest pain
! style="background:#4479BA; color: #FFFFFF;" align="center" |Clubbing
! style="background:#4479BA; color: #FFFFFF;" align="center" |Clubbing
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral edema
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral edema
! style="background:#4479BA; color: #FFFFFF;" align="center" |Auscultation
! style="background:#4479BA; color: #FFFFFF;" align="center" |Auscultation
! style="background:#4479BA; color: #FFFFFF;" align="center" |Lab Findings
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Lab Findings
! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard
! style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
|-
! rowspan="14" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Respiratory
! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Airway
disorder
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Severe [[croup]]<ref name="Cherry2008">{{cite journal|last1=Cherry|first1=James D.|title=Croup|journal=New England Journal of Medicine|volume=358|issue=4|year=2008|pages=384–391|issn=0028-4793|doi=10.1056/NEJMcp072022}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Audible [[stridor]] at rest
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Lymphocytosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |AP Neck X ray for soft tissues:
* [[Steeple sign]]
Lateral neck X ray:
* Distended [[hypopharynx]] during [[inspiration]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Clinical diagnosis
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Croupy cough and [[stridor]]
* Intercostal, subcostal retractions
|-
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Epiglottitis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Stridor]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Leukocytosis]] with [[neutrophilia]]
* Blood cultures
* Throat culture in intubated patients
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Lateral neck X ray
* [[Thumbprint sign]] (swollen epiglottis)
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Laryngoscopy]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Sore Throat]]
* [[Dysphagia]]
* [[Odynophagia]]
* Muffled voice
* Drooling
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Coma]]
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Coma]]
Line 581: Line 1,097:
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
! colspan="2" rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Miscellaneous
! colspan="2" rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Miscellaneous
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Shock]]
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Shock]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
Line 599: Line 1,115:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
Line 605: Line 1,121:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Toxic gases
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ±
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
Line 627: Line 1,129:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
Line 634: Line 1,136:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Fingerstick glucose (Hyperglycemia)
*[[Complete blood count|CBC]]
*Electrocardiogram (ECG) may show J wave, sinus bradycardia and prolongation of all ECG intervals.  
*Fingerstick glucose (Hyperglycemia)
 
*EKG-
*Serum electrolytes (including potassium and calcium)
**J wave
**Sinus bradycardia
**Prolongation of all ECG intervals.


*BUN and creatinine
*Serum electrolytes -K+ and calcium


*Serum hemoglobin, white blood cell, and platelet counts ( Raised HCT due to volume contraction)
*[[BUN]] and [[creatinine]]


*Coagulation profile (clotting factors impairment)
*[[PT]], [[PTT]]


*Serum lactate ( lactic acidosis)
*S. [[lactate]]


*Creatine kinase (Rhabdomylosis)
*ABG
 
*Arterial blood gas
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* CXR
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*'''Mild hypothermia''': core temperature 32 to 35°C ;
**[[Confusion]]
**[[Tachycardia]]
**Increased shivering.
*'''Moderate hypothermia''': 28 to 32°C
**[[Lethargy]]
**[[Bradycardia]]
**[[Arrhythmia]]
**Decreased shivering.
*'''Severe hypothermia''': <28°C
**[[Coma]]
**[[Hypotension]]
**[[Arrhythmias|Arrhythmia]]
**[[Pulmonary edema]]
**Rigidity
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Drugs†
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Drugs†
Line 672: Line 1,190:
|}
|}


Sinusoidal changes induced by pyrrolizidine alkaloids and myeloablative agents are likely the results of a combination of: i) a direct, dose-related toxicity to sinusoidal and central venous endothelial cell, and ii) the effect of chemotherapy on bone marrow progenitors of endothelial cells that are mobilized for the repair of sinusoidal lesions. It is difficult to ascertain whether the associated liver cell damage is a pure result of sinusoidal injury, or a result of combined sinusoidal injury and direct toxicity on liver cells. There is evidence for a generalized alteration of endothelia in animal models of pyrrolizidine alkaloid toxicity but also in recipients of HSCT, when they develop SOS/VOD [54]. These changes include features of endothelial activation and apoptosis [54]. Sinusoidal changes found in patients receiving chemotherapy for hepatic metastasis of colorectal adenocarcinoma may result from similar mechanisms despite a much less severe clinical and histological expression, or may stem from different pathways implicating proinflammatory mediators. Decreasing the intensity of chemotherapeutic regimen is currently the only proven means to prevent or decrease the severity of sinusoidal changes and their clinical expression. Long-term effect of low intensity regimens will have to be assessed. Indeed, portal hypertension due to nodular regenerative hyperplasia may represent a more common sequela of infraclinical sinusoidal damage than currently recognized [55]. Elucidation of the mechanisms underlying the recently reported SP110 mutations associated familial SOS/VOD occurring in the absence of exposure to chemotherapy or related agents [52] will shed light on the mechanisms involved when such agents.
Obliterative endophlebitis in the terminal hepatic veins of the human liver lobule was first reported by a pathologist from Prague in 1905, with the only etiologic suggestion being syphilis.1 In 1954, terminal vein lesions were described in Jamaican drinkers of bush tea, characterized by obliteration of hepatic vein radicals by varying amounts of subendothelial swelling and fine reticulated tissue.2 At later stages, a fibrous pericentral scar developed. In the early 1960's, studies of the effects of ionizing radiation on mammalian tissues documented that the hepatic vasculature could be damaged by this mechanism,3 in the absence of antecedent vascular thrombosis.4,5 The most striking example of an obliterative venous lesion induced by irradiation was documented in humans with lung tumors receiving radiation treatment; both the lung vasculature and that of the dome of the liver that was included in the radiation field developed vascular obliteration, but not the remainder of the unexposed liver.6 Shortly thereafter, induction of obliterative venopathy following heavy irradiation directly of the human liver for metastatic disease was reported in 12 patients receiving upper abdominal irradiation by the Stanford Linear Accelerator.7 Thus, by the mid-1960s, the concept of hepatic veno-occlusive disease was well-established, induced by either chemical or radiation toxicity, and as a lesion separate from Budd-Chiari syndrome and Banti syndrome.8,9


In the late 1970's, similar histologic lesions were reported from outbreaks in India and Israel, attributed to contamination of wheat and traditional herbal remedies with plant toxins.10,11 The histological lesions resembled previously described hepatic veno-occlusive lesions described in rats poisoned with Senecio plant extracts12 or Crotolaria.13 This form of liver toxicity was ultimately attributed to hepatic exposure to plant pyrrolizidine alkaloids,14 establishing these plant toxins as the cause of veno-occlusive disease in users of herbal teas.


Bone marrow transplantation for humans with leukemias became a therapeutic option during the 1960s. Initial challenges to this new therapy were preservation of harvested marrow, and achieving successful marrow engraftment.15 Reports of hepatic veno-occlusive disease in patients undergoing bone marrow transplantation emerged in the 1970's,16 followed by numerous reports which established the following apparent risk factors: bone marrow transplantation for malignancy, involving intense chemotherapeutic and radiation conditioning regimens; patient age over 15 years; and in particular, abnormal pretransplant serum levels of liver enzymes.17–19 The presence of metastatic liver disease in patients undergoing bone marrow transplantation for solid tumors and lymphomas also predisposed to veno-occlusive disease.20,21 In these initial years after recognition of veno-occlusive disease as a complication of induction regimes prior to bone marrow transplantation, the incidence of veno-occlusive disease varied from 21% to 25% in allogeneic graft recipients,19,21,22 to 5% in recipients of autologous marrow.20,23,24 In the four decades since routine use of bone marrow transplantation for solid malignancies, lymphomas and leukemias, induction regimes and therapies have helped improve, but not eliminate, the incidence of this condition in the transplant population. Its incidence now is primarily in the setting of hematopoietic stem cell transplantation, but SOS may occur in other settings as well




<references />


==Differential diagnosis==


A central pathogenic event is toxic destruction of hepatic sinusoidal endothelial cells (SEC), with sloughing and downstream occlusion of terminal hepatic venules.
<span style="font-size:85%">'''Abbreviations:'''
 
AP= Anteroposterior, CXR= [[Chest X-ray]], CT= [[Computed tomography]], ABG= [[Arterial blood gas]], V/Q= [[Ventilation/perfusion scan]] , EKG= [[Electrocardiogram]], COPD= [[Chronic obstructive pulmonary disease]], BNP= [[Brain natriuretic peptide]], DVT= [[Deep vein thrombosis]], HRCT= [[High Resolution CT]], IgE= [[Immunoglobulin E]]</span>   
<ref name="pmid17326150">{{cite journal |author=Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R |title=Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy |journal=Hepatology |volume=45 |issue=3 |pages=549-59 |year=2007 |pmid=17326150 |doi=10.1002/hep.21533}}</ref><ref name="Ferenci" /><ref name="Conn">Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72: 573-83.</ref>
{| align="center"
 
Sinusoidal obstruction syndrome (SOS) occurs due to obstruction of the hepatic venules and sinusoids rather than hepatic vein or inferior vena cava as seen in Budd Chiari syndrome.
Hepatic sinusoidal obstruction syndrome (SOS) is mainly seen in hematopoietic cell transplantation.
The development of sinusoidal obstruction syndrome (SOS) begins with the injury to the hepatic venous endothelium. It is thought that preexisting liver disease increases the risk of developing sinusoidal obstruction syndrome (SOS) due to impairment of drug metabolism which predisposes to the endothelial injury.
The endothelial cells in patients with hepatitis may have abnormal expression of adhesion molecules and procoagulant factors.
The deposition of fibrinogen and factor VIII within the sinusoids leads to their dilation and congestion by erythrocytes. The progressive occlusion of venules leads to widespread zonal liver disruption and centrilobular hemorrhagic necrosis.
The later changes in sinusoids include deposition of collagen, sclerosis of venular walls, fibrosis of the lumens and ultimately occlusion of hepatic venules.
The severity of symptoms depends on the number of sinusoids involve and severity of the histologic changes.
 
 
 
 
 
 
 
 
 
:❑ In the absence of ICP monitors
::❑ Hourly neurological evaluation
::❑ Monitoring of serum ammonia levels
::❑ Transcranial ultrasonography
 
b) '''Prophylactic hypertonic saline: (I)''':❑ Hypertonic saline i.v bolus (20 ml of 30% sodium chloride or 200 ml of 3% sodium chloride)<ref name="Wendon-2008">{{Cite journal  | last1 = Wendon | first1 = J. | last2 = Lee | first2 = W. | title = Encephalopathy and cerebral edema in the setting of acute liver failure: pathogenesis and management. | journal = Neurocrit Care | volume = 9 | issue = 1 | pages = 97-102 | month = | year = 2008 | doi = 10.1007/s12028-008-9123-6 | PMID = 18688582 }}</ref> for prophylactic induction of [[hypernatremia]] in patients with
 
::❑ Serum ammonia >150 μM
 
::❑ Grade III/IV hepatic encephalopathy
 
::❑ [[Acute renal failure]]
 
::❑ [[Vasopressors]] requirement to maintain [[Mean arterial pressure|MAP]]
 
:❑ Maintain serum sodium level of 145-155 mEq/L
 
c) '''Intracranial hypertension treatment:'''
 
:❑ I line therapy: '''(II-2)'''
 
::❑ [[Mannitol]] i.v bolus (0.5-1.0 gm/kg of body weight or 2 ml of 20% solution/kg of body weight)<ref name="Wendon-2008">{{Cite journal  | last1 = Wendon | first1 = J. | last2 = Lee | first2 = W. | title = Encephalopathy and cerebral edema in the setting of acute liver failure: pathogenesis and management. | journal = Neurocrit Care | volume = 9 | issue = 1 | pages = 97-102 | month =  | year = 2008 | doi = 10.1007/s12028-008-9123-6 | PMID = 18688582 }}</ref>
 
::❑ Administered as needed as long as serum osmolality <320 mOsm/L
 
:❑ II line therapy: (if refractory to mannitol) '''(II-3)'''
 
::❑ [[Secobarbital|Short-acting barbiturates]]
::❑ [[Hypothermia]] induction to a core body temperature of 34°-35°C
::❑ Indomethacin i.v bolus (0.5 mg/kg) may be used when cerebral hyperemia is also present<ref name="Wendon-2008">{{Cite journal  | last1 = Wendon | first1 = J. | last2 = Lee | first2 = W. | title = Encephalopathy and cerebral edema in the setting of acute liver failure: pathogenesis and management. | journal = Neurocrit Care | volume = 9 | issue = 1 | pages = 97-102 | month = | year = 2008 | doi = 10.1007/s12028-008-9123-6 | PMID = 18688582 }}</ref>
 
:❑ Goals of intracranial hypertension treatment<ref name="Hoofnagle-1995">{{Cite journal  | last1 = Hoofnagle | first1 = JH. | last2 = Carithers | first2 = RL. | last3 = Shapiro | first3 = C. | last4 = Ascher | first4 = N. | title = Fulminant hepatic failure: summary of a workshop. | journal = Hepatology | volume = 21 | issue = 1 | pages = 240-52 | month = Jan | year = 1995 | doi =  | PMID = 7806160 }}</ref>
 
::ICP <20 mmHg
 
::CPP >60 mmHg
 
:❑ Hyperventilate to PaCO2 of 25-30 mmHg (in case of impending herniation)<ref name="Laffey-2002">{{Cite journal  | last1 = Laffey | first1 = JG. | last2 = Kavanagh | first2 = BP. | title = Hypocapnia. | journal = N Engl J Med | volume = 347 | issue = 1 | pages = 43-53 | month = Jul | year = 2002 | doi = 10.1056/NEJMra012457 | PMID = 12097540 }}</ref>
|-
|-
| '''Grade I/II encephalopathy'''|| ❑ Frequent neurological assessment with avoidance of stimulation and sedation<br> ❑ Small doses of short-acting [[benzodiazepines]] in case of unmanageable agitation<br> ❑ Stat brain [[CT]] to rule out other causes of altered mental status<br> ❑ Consideration for transfer to a liver transplant facility and listing for transplantation at the earliest<br> ❑ [[Lactulose]] (possibly helpful and may interfere with surgical field by increasing bowel distention during liver transplantation) '''(III)'''<br> ❑ Infection surveillance<br>  ❑ Antibiotic prophylaxis against infections (possibly helpful)<br> ❑ Infection treatment as required
|
[[Seizure|<nowiki/>]]
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
! colspan="2" rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Causes of cyanosis
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
! colspan="2" rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Cyanosis
| colspan="6" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Clinical manifestations/association'''
! colspan="3" rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Diagnosis
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Additional
findings
|-
|-
| '''Grade III/IV encephalopathy'''||Besides managing the patient similar to grade I/II encephalopathy
| colspan="3" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Symptoms'''
:❑ Intubate trachea (might require sedation) '''(III)'''
! colspan="3" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Signs
:❑ Muscle relaxants for intubation<ref name="Stravitz-2009">{{Cite journal  | last1 = Stravitz | first1 = RT. | last2 = Kramer | first2 = DJ. | title = Management of acute liver failure. | journal = Nat Rev Gastroenterol Hepatol | volume = 6 | issue = 9 | pages = 542-53 | month = Sep | year = 2009 | doi = 10.1038/nrgastro.2009.127 | PMID = 19652652 }}</ref><ref name="Wijdicks-2002">{{Cite journal  | last1 = Wijdicks | first1 = EF. | last2 = Nyberg | first2 = SL. | title = Propofol to control intracranial pressure in fulminant hepatic failure. | journal = Transplant Proc | volume = 34 | issue = 4 | pages = 1220-2 | month = Jun | year = 2002 | doi =  | PMID = 12072321 }}</ref>
::During intubation: [[Atracurium|Depolarizing neuro-muscular blocking agents]]
::After intubation: [[Propofol]]
:❑ Elevate head of bed to 30°<ref name="Durward-1983">{{Cite journal  | last1 = Durward | first1 = QJ. | last2 = Amacher | first2 = AL. | last3 = Del Maestro | first3 = RF. | last4 = Sibbald | first4 = WJ. | title = Cerebral and cardiovascular responses to changes in head elevation in patients with intracranial hypertension. | journal = J Neurosurg | volume = 59 | issue = 6 | pages = 938-44 | month = Dec | year = 1983 | doi = 10.3171/jns.1983.59.6.0938 | PMID = 6631516 }}</ref>
:❑ [[Lidocaine]] administration during endotracheal suctioning
:❑ Immediate treatment of seizures with [[phenytoin]] and [[benzodiazepines]] with short half-lives '''(III)'''
:❑ ICP monitoring with devices
:❑ Mannitol administration following severe elevation of ICP or first clinical sign of herniation
:❑ Hypertonic saline administration to raise serum sodium to 145-155 mmol/L
:❑ Hyperventilate patient in case of impending herniation
:❑ Monitor and manage hemodynamic and renal parameters as well as glucose, electrolytes and acid/base status
|-
|-
| '''Cardiovascular System'''|| '''Hemodynamic abnormalities'''|| ❑ Fluid resuscitation and maintenance of adequate intravascular volume (initiate hypotension treatment with intravenous normal saline) '''(III)'''<br> ❑ Systemic vasopressor support ([[dopamine]], [[epinephrine]], [[norepinephrine]]) as needed '''(II-1)'''<br> ❑ [[Vasopressin]]or[[terlipressin]] added to norepinephrine in norepinephrine-refractory cases (used cautiously in severely encephalopathic patients with intracranial hypertension) '''(II-1)'''<br> ❑ Ensure appropriate volume status with a volume challenge (pulmonary artery catheterization is rarely necessary since it is associated with significant morbidity) '''(III)'''<br> ❑ [[Echocardiography]] for low cardiac output and right ventricular failure<br> ❑ Goals of circulatory support: '''(II)'''
! style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
: MAP ≥75 mmHg
! style="background:#4479BA; color: #FFFFFF;" align="center" |Central
: [[CPP]] 60-80 mmHg
! style="background:#4479BA; color: #FFFFFF;" align="center" |Dyspnea
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Fever
! style="background:#4479BA; color: #FFFFFF;" align="center" |Chest pain
! style="background:#4479BA; color: #FFFFFF;" align="center" |Clubbing
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral edema
! style="background:#4479BA; color: #FFFFFF;" align="center" |Auscultation
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Lab Findings
! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard
|-
|-
|'''Respiratory System'''|| '''Aspiration pneumonitis'''|| ❑ Neurologic observation to monitor level of consciousness<br> ❑ Early endotracheal intubation for depressed level of consciousness
! rowspan="13" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Respiratory
! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Airway
disorder
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Severe [[croup]]<ref name="Cherry20082">{{cite journal|last1=Cherry|first1=James D.|title=Croup|journal=New England Journal of Medicine|volume=358|issue=4|year=2008|pages=384–391|issn=0028-4793|doi=10.1056/NEJMcp072022}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Audible [[stridor]] at rest
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Lymphocytosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |AP Neck X ray for soft tissues:
*[[Steeple sign]]
Lateral neck X ray:
*Distended [[hypopharynx]] during [[inspiration]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Croupy cough and [[stridor]]
*Intercostal, subcostal retractions
|-
|-
|'''Hepatic System'''||'''Hepatic dysfunction'''|| ❑ NAC administration (acetaminophen as well as non-acetaminophen ALF)
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Epiglottitis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Stridor]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Leukocytosis]] with [[neutrophilia]]
*Blood cultures
*Throat culture in intubated patients
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Lateral neck X ray
*[[Thumbprint sign]] (swollen epiglottis)
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Laryngoscopy]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Sore Throat]]
*[[Dysphagia]]
*[[Odynophagia]]
*Muffled voice
*Drooling
|-
|-
| '''Metabolic and Renal System'''|| '''Metabolic abnormalities and renal failure'''|| ❑ Frequent monitoring and correction of derangements in glucose, potassium, magnesium and phosphate '''(III)'''<br> ❑ Continuous modes of hemodialysis (if needed) '''(I)'''
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Foreign body aspiration]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*Decreased breath sounds
*[[Wheezing]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[ABG|ABGs]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CXR
*Hyperinflation (children)
*[[Atelectasis]] (adults)
*Objects
[[CT scan]]
*Foreign body
*Entrapment with [[edema]] or [[granulation tissue]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Bronchoscopy]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Complications:
*Inflammation
*[[Mediastinitis]]
*Local [[emphysema]]
*[[Atelectasis]]
*Cyanosis
|-
|-
| '''Hematologic System'''|| '''Coagulopathy'''|| ❑ Replacement therapy for [[thrombocytopenia]] and/or prolonged prothrombin time with platelet and [[FFP]] transfusion respectively in the setting of active bleeding or before invasive procedure '''(III)'''<br> ❑ [[Vitamin K]] (5-10 mg subcutaneously) (at least one dose)<ref name="Pereira-2005">{{Cite journal  | last1 = Pereira | first1 = SP. | last2 = Rowbotham | first2 = D. | last3 = Fitt | first3 = S. | last4 = Shearer | first4 = MJ. | last5 = Wendon | first5 = J. | last6 = Williams | first6 = R. | title = Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease. | journal = J Hepatol | volume = 42 | issue = 3 | pages = 365-70 | month = Mar | year = 2005 | doi = 10.1016/j.jhep.2004.11.030 | PMID = 15710219 }}</ref><br> ❑ Plasmapheresis or recombinant activated factor VII (rFVIIa) in case of inadequate correction of severely elevated INR and risks of volume overload<br> ❑ Maintenance of adequate platelet count
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Bacterial tracheitis]]
:In the absence of bleeding: >10,000/mm<sup>3</sup><ref name="Heckman-1997">{{Cite journal  | last1 = Heckman | first1 = KD. | last2 = Weiner | first2 = GJ. | last3 = Davis | first3 = CS. | last4 = Strauss | first4 = RG. | last5 = Jones | first5 = MP. | last6 = Burns | first6 = CP. | title = Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL. | journal = J Clin Oncol | volume = 15 | issue = 3 | pages = 1143-9 | month = Mar | year = 1997 | doi =  | PMID = 9060557 }}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
:For performing invasive procedures: 50-70,000/ mm<sup>3</sup><br>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
❑ Prophylaxis for stress ulceration: '''(I)'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
:❑ I line: [[H2 blocker]] or [[PPI]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
:❑ II line: [[Sucralfate]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*Inspiratory [[stridor]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Blood cultures]]
*[[Gram stain]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Lateral neck X ray
*Confusing
*[[Steeple sign]]
*Irregular tracheal margin
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Laryngotracheo[[Bronchoscopy|-bronchoscopy]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Brassy cough
*Retractions
*No drooling
*Hoarseness
|-
|-
| '''Immunologic System'''|| '''Infection'''|| ❑ Periodic surveillance for prompt initiation of antimicrobial treatment of infections at the earliest sign of active infection or deterioration (progression to high grade hepatic encephalopathy or elements of the [[SIRS]]) '''(III)'''<br> ❑ Antibiotic prophylaxis (possibly helpful in patients with coagulopathy, organ failure, encephalopathy and in whom illness progression is considered likely - not proven) '''(III)'''
! style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
|}
! style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
 
! style="background:#4479BA; color: #FFFFFF;" align="center" |Central
{| class="wikitable sortable"
! style="background:#4479BA; color: #FFFFFF;" align="center" |Dyspnea
!Etiology
! style="background:#4479BA; color: #FFFFFF;" align="center" |Fever
!Diagnostic Indicators
! style="background:#4479BA; color: #FFFFFF;" align="center" |Chest pain
!Management Recommendations
! style="background:#4479BA; color: #FFFFFF;" align="center" |Clubbing
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral edema
! style="background:#4479BA; color: #FFFFFF;" align="center" |Auscultation
! style="background:#4479BA; color: #FFFFFF;" align="center" |Lab Findings
! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
|-
|-
|'''Acetaminophen toxicity''' ||❑ H/o of acetaminophen intake (toxic dose >10 gm/day or >150 mg/kg)<BR>❑ Acetaminophen in blood and/or urine<BR>❑ [[Aminotransferase]] levels >3500 IU/L with low bilirubin levels, in the absence of apparent hypotension or cardiovascular collapse (suspected acetaminophen toxicity in the absence of a positive history because acetaminophen is the leading cause of ALF at least in the United States and Europe)<ref name="Ostapowicz-2002">{{Cite journal  | last1 = Ostapowicz | first1 = G. | last2 = Fontana|first2 = RJ. | last3 = Schiødt | first3 = FV. | last4 = Larson | first4 = A. | last5 = Davern | first5 = TJ. | last6 = Han | first6 = SH. | last7 = McCashland|first7 = TM. | last8 = Shakil | first8 = AO. | last9 = Hay | first9 = JE. | title = Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. | journal = Ann Intern Med | volume = 137 | issue = 12 | pages = 947-54 | month = Dec | year = 2002 | doi =  | PMID = 12484709 }}</ref>||❑'''Activated charcoal:'''<br>1g/kg PO within 1 hour after drug ingestion (may be beneficial even when administered within 3-4 hours after ingestion)<ref name="Sato-2003">{{Cite journal  | last1 = Sato | first1 = RL. | last2 = Wong | first2 = JJ. | last3 = Sumida | first3 = SM. | last4 = Marn | first4 = RY. | last5 = Enoki | first5 = NR. | last6 = Yamamoto | first6 = LG. | title = Efficacy of superactivated charcoal administered late (3 hours) after acetaminophen overdose. | journal = Am J Emerg Med | volume = 21 | issue = 3 | pages = 189-91 | month = May | year = 2003 | doi =  | PMID = 12811710 }}</ref> and prior to starting [[NAC]] '''(I)'''<br>❑ '''[[Nomogram]]''' (helps determining the likelihood of serious liver damage but does not exclude possible toxicity)<br>❑ '''NAC:''' <br>140 mg/kg PO or through NGT (diluted to 5% solution), then 70 mg/kg PO q4h x 17 doses<br>'''or'''<br>IV loading dose of 150 mg/kg in 5% dextrose over 15 minutes, then maintenance dose of 50 mg/kg IV over the next 4 hours and then 100 mg/kg IV over the following 16 hours<br>*Promptly begin NAC (beneficial even when administered <48 hours after drug ingestion) in all patients with impending or evolving liver injury due to acetaminophen '''(II-1)'''<br>*NAC may be used in cases of ALF due to suspected acetaminophen poisoning '''(III)'''<br>*NAC is recommended even in case of non-acetaminophen ALF<ref name="Lee-2009">{{Cite journal  | last1 = Lee | first1 = WM. | last2 = Hynan | first2 = LS. | last3 = Rossaro | first3 = L. | last4 = Fontana | first4 = RJ. | last5 = Stravitz | first5 = RT. | last6 = Larson | first6 = AM. | last7 = Davern | first7 = TJ. | last8 = Murray | first8 = NG. | last9 = McCashland | first9 = T. | title = Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. | journal = Gastroenterology | volume = 137 | issue = 3 | pages = 856-64, 864.e1 | month = Sep | year = 2009 | doi = 10.1053/j.gastro.2009.06.006 | PMID = 19524577 }}</ref>
! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Parenchymal
disorder
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pneumonia]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*Reduced breath sounds
*Rales, [[crackles]], wheeze
*[[Pleural friction rub]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[ABG|ABGs]]
*Leukocytosis
*Pancytopenia
*[[Hyponatremia]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*CXR
*CT chest
*Bronchoscopy
*Sputum culture and gram stain
*Blood cultures
*Urine antigen
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Tachycardia]]
*[[Bradycardia]] ([[Legionella]])
*[[CURB-65]]
|-
|-
|'''Acute fatty liver of pregnancy/HELLP''' ||❑ Jaundice and hypertension<br>❑ Coagulopathy<br>❑ Thrombocytopenia<br>❑ Proteinuria<br>❑ Hypoglycemia<br>❑ [[Steatosis]] in liver imaging or biopsy ||❑ Early diagnosis and prompt delivery '''(III)'''<br>❑ Adequate supportive care<br>❑ Consider transplantation for postpartum deterioration '''(III)'''
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Asthma]]
(Late)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔ in [[interstitial lung disease]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*End expiratory [[wheeze]]
*Absent [[wheeze]] and breath sounds in severe form
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[ABG]]
*[[Eosinophilia]]
*[[IgE]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CXR
*to rule out other diagnosis
*complications like pneumonia, [[atelactasis]]
HRCT
*[[Allergic bronchopulmonary aspergillosis]]
*[[Bronchiectasis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Reversible obstructive disease
*[[Peak expiratory flow]] measurement is easy and very helpful
*[[GERD]] is a cause in case of refractory asthma.
*Triad of [[asthma]], [[nasal polyps]] and [[rash]] is indicative of [[Aspirin desensitization|aspirin sensitivity]].
|-
|-
|'''Acute ischemic injury''' ||❑ H/o cardiac arrest<br>❑ Any period of significant hypovolemia/hypotension, or severe [[CHF]] (hypotension is not documented always)<br>❑ Any associated renal dysfunction & muscle necrosis<br>❑ Elevated aminotransferase levels responding to fluid resuscitation||❑ Adequate cardiovascular support '''(III)'''
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cystic fibrosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |when infected
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Wheeze]] or crackles
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Sputum stain and culture
*[[Sweat test]]
*Genetic test for [[CFTR (gene)]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CXR
*Hyperinflation
*Peribronchial thickening
*Nodules
*[[Bronchiectasis]]
HRCT for detecting lung changes
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Sweat test
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Usually present since birth
*Recurrent pneumonia
*Recurrent wheezing
*Recurrent sinusitis
*Gastrointestinal manifestations
**[[Meconium ileus]]
**[[Pancreatic insufficiency]]
|-
|-
|'''Autoimmune''' ||❑ Positive serum autoantibodies (may be absent)<br>❑ Positive liver biopsy (confirms diagnosis when [[autoimmune hepatitis]] is suspected and autoantibodies are negative) '''(III)''' ||[[Prednisolone]] (start with 40-60 mg/day, especially in the presence of coagulopathy and mild hepatic encephalopathy) '''(III)'''<br>❑ Consider transplantation and do not delay while awaiting response to steroid treatment '''(III)'''
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[COPD]]
(Severe [[emphysema]])
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*Reduced breath sounds
*Prolonged  expiration
*[[Wheeze]]
*Inspiratory [[crackles]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Hematocrit]]
*[[ABG]]
*Sputum staining and culture
*[[Alpha 1-antitrypsin deficiency laboratory tests|Alpha 1-antitrypsin test]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CXR
*Elongated heart
*Flattening of diaphragms
*Prominent hilar vasculature
HRCT
*Bullae
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*HRCT
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Pulmonary hypertension]]
*[[Right heart failure]]
|-
|-
|'''Budd-Chiari''' ||❑ Abdominal pain<br>❑ Ascites<br> ❑ Hepatomegaly<br>❑ Blood tests positive for hypercoagulability<br>❑ Positive findings during liver imaging ([[CT]], [[Medical ultrasonography#Doppler sonography|doppler USG]], [[venography]] or magnetic resonance venography) (confirms diagnosis) ||❑ Liver transplantation (provided underlying malignancy is excluded) '''(II-3)'''
! style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
! style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
! style="background:#4479BA; color: #FFFFFF;" align="center" |Central
! style="background:#4479BA; color: #FFFFFF;" align="center" |Dyspnea
! style="background:#4479BA; color: #FFFFFF;" align="center" |Fever
! style="background:#4479BA; color: #FFFFFF;" align="center" |Chest pain
! style="background:#4479BA; color: #FFFFFF;" align="center" |Clubbing
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral edema
! style="background:#4479BA; color: #FFFFFF;" align="center" |Auscultation
! style="background:#4479BA; color: #FFFFFF;" align="center" |Lab Findings
! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
|-
|-
|'''Drug induced''' ||❑ H/o hepatotoxic drug intake (usually idiosyncratic hepatotoxic drug intake within first 6 months after drug initiation; continuous usage of potentially hepatotoxic drug for more than 1 to 2 years is unlikely to cause de novo liver damage)<br>❑ H/o inclusive of details (including onset of ingestion, amount and timing of last dose) concerning all prescription and non-prescription drugs, herbs and dietary supplements taken over the past year '''(III)'''<br>❑ Determine ingredients of non-prescription medications whenever possible '''(III)''' ||❑ Discontinue all but essential medications in the setting of possible drug hepatotoxicity '''(III)'''<br>❑ NAC (may be beneficial for ALF induced by drugs) '''(I)'''
! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Pulmonary vascular disorders
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Massive [[pulmonary embolism]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*Reduced breath sounds
*Rales, crackles
*Loud [[P2]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[ABG|ABGs]]
*D-dimer
*EKG
*[[BNP]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*CXR
*V/Q scan
*Spiral [[CT pulmonary angiogram]]
*Venous ultrasound for [[DVT]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Spiral [[CT pulmonary angiogram]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Tachycardia]]
*[[Shock]]
*[[Pulmonary hypertension]] can occur
|-
|-
|'''Malignant infiltration''' ||Massive hepatomegaly<br>❑ Malignant infiltration in liver imaging or liver biopsy (confirms or excludes diagnosis) '''(III)'''||❑ Appropriate management of underlying malignancy<br>❑ Supportive care
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pulmonary arterio-venous malformation]]<ref name="pmid119300212">{{cite journal |vauthors=Khurshid I, Downie GH |title=Pulmonary arteriovenous malformation |journal=Postgrad Med J |volume=78 |issue=918 |pages=191–7 |year=2002 |pmid=11930021 |pmc=1742331 |doi= |url=}}</ref><ref name="pmid195683982">{{cite journal |vauthors=Doshi HM, Robinson S, Chalhoub T, Jack S, Denison A, Gibson G |title=Massive spontaneous hemothorax during the immediate postpartum period |journal=Tex Heart Inst J |volume=36 |issue=3 |pages=247–9 |year=2009 |pmid=19568398 |pmc=2696501 |doi= |url=}}</ref><ref name="pmid15541322">{{cite journal |vauthors=Chanatry BJ |title=Acute hemothorax owing to pulmonary arteriovenous malformation in pregnancy |journal=Anesth. Analg. |volume=74 |issue=4 |pages=613–5 |year=1992 |pmid=1554132 |doi= |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*Pulmonary bruit
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[CBC]]
*[[ABG]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CXR
*Round/oval mass
**lobulated
**well defined
*Connecting vessel in hilum
*[[Hemothorax]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Pulmonary angiography]]
*Contrast [[echocardiography]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Classic triad of [[dyspnea on exertion]], [[cyanosis]] and [[clubbing]]
*[[Cerebral arteriovenous malformation]]
*[[Pregnancy]] can increase the size
|-
|-
|'''Mushroom poisoning''' ||❑ H/o recent mushroom intake<br>❑ Severe GI symptoms like nausea, vomiting and diarrhea within hours or a day of ingestion (suspected mushroom poisoning in the absence of a positive history) ||❑ Early gastric lavage and activated charcoal administration<br>❑ [[Penicillin|Penicillin G]] 300,000-1 million units/kg/day<br>'''or'''<br>[[Silibinin]] 30-40 mg/kg/day IV or PO, 3-4 days (silymarin in Europe and south America; milk thistle in north America)<ref name="Enjalbert-2002">{{Cite journal  | last1 = Enjalbert | first1 = F. | last2 = Rapior | first2 = S. | last3 = Nouguier-Soulé | first3 = J. | last4 = Guillon | first4 = S. | last5 = Amouroux | first5 = N. | last6 = Cabot | first6 = C. | title = Treatment of amatoxin poisoning: 20-year retrospective analysis. | journal = J Toxicol Clin Toxicol | volume = 40 | issue = 6 | pages = 715-57 | month =  | year = 2002 | doi = | PMID = 12475187 }}</ref><br>❑ NAC '''(III)'''<br>❑ Liver transplantation (the only lifesaving option) '''(III)'''<br>❑ Fluid resuscitation (as needed)
! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Chest <br> wall disorders
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Flail chest]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
|'''Viral''' ||❑ Toxically appearing patients with skin lesions (HSV)<br>❑ Positive hepatitis virus serology<br>❑ [[HSV]] positive liver biopsy ||❑ Supportive treatment (no virus specific treatment proven to be effective) '''(III)'''<BR>❑ Nucleoside and nucleotide analogues (for [[HBV]] associated ALF) '''(III)'''<BR>❑ [[Acyclovir]] (5-10 mg/kg every 8 hours for at least 7 days for HSV or VZV) '''(III)'''
! rowspan="13" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Cardiovascular
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pneumothorax]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*Decreased breath sounds
*[[Wheezing]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
|-
|-
|'''Wilson's disease''' ||❑ KF ring<br>❑ Serum bilirubin >20 mg/dL,<br>❑ Bilirubin:alkaline phosphatase >2.0<br>❑ Low serum ceruloplasmin<br>❑ Elevated serum & urine copper<br>❑ High copper levels in liver biopsy '''(III)'''||❑ Liver transplantation '''(III)'''<br>❑ Dialysis or hemofiltration or plasmapheresis or plasma exchange
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |
| style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
| style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
| style="background:#4479BA; color: #FFFFFF;" align="center" |Central
| style="background:#4479BA; color: #FFFFFF;" align="center" |Dyspnea
| style="background:#4479BA; color: #FFFFFF;" align="center" |Fever
| style="background:#4479BA; color: #FFFFFF;" align="center" |Chest pain
| style="background:#4479BA; color: #FFFFFF;" align="center" |Clubbing
| colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral edema
| style="background:#4479BA; color: #FFFFFF;" align="center" |Auscultation
| style="background:#4479BA; color: #FFFFFF;" align="center" |Lab Findings
| style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging
| style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard
| style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
|-
|-
|'''Intermediate etiology''' ||❑ Etiology undetermined after all evaluation||❑ Review drug and toxin intake H/o<BR>❑ Transjugular biopsy (for further evaluation of possible mailgnancy, [[Wilson disease]], autoimmune hepatitis and [[viral hepatitis]]) '''(III)'''
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |
|}
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |
[[Atrioventricular canal defect (patient information)|Atrioventricular canal defect]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +


<div class="mw-collapsible mw-collapsed">
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CBC]]
* [[EKG]]
* [[Pulse oximetry]]


| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]] (Cardiac enlargement, Increased pulmonary vascular markings)


*[[Echocardiography]]
*[[MRI]]
*[[Cardiac catheterization]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
** [[Echocardiography]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Ebstein anomaly]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
* [[CBC]]
* [[EKG]]
* [[Pulse oximetry]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]] (Cardiac enlargement, decreased pulmonary vascular markings)
* [[Echocardiography]]
* [[MRI]]
* [[Cardiac catheterization]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Echocardiography]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Tetralogy of Fallot]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + (systolic)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
* [[CBC]]
* [[EKG]]
* [[Pulse oximetry]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[CXR]] (Boot shaped heart, decreased pulmonary vascular markings)
*[[Echocardiography]]
*[[MRI]]
*[[Cardiac catheterization]]
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Echocardiography]]
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pulmonic stenosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + (systolic)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
* [[CBC]]
* [[EKG]]
* [[Pulse oximetry]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]] (Cardiac enlargement, decreased pulmonary vascular markings)


===Liver Biopsy===
* [[Echocardiography]]
A [[liver biopsy]] done via the [[jugular|transjugular]] route because of [[coagulopathy]] is not usually necessary other than in occasional malignancies.
* [[MRI]]
* [[Cardiac catheterization]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Echocardiography]]
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Total anomalous pulmonary venous drainage|Total anomalous pulmonary]] [[Total anomalous pulmonary venous drainage|venous connection]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + (Systolic)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
* [[CBC]]
* [[EKG]]
* [[Pulse oximetry]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]] (normal heart size and venous congestion but in patients without obstruction have cardiomegaly and increased pulmonary blood flow.)


As the evaluation continues, several important decisions have to be made such as whether to admit the patient to an ICU, or whether to transfer the patient to a transplant facility. Consultation with the transplant centre as early as possible is critical due to possibility of rapid progression of ALF.
* [[Echocardiography]]
* [[MRI]]
* [[Cardiac catheterization]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Echocardiography]]
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Transposition of the great vessels]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
* [[CBC]]
* [[EKG]]
* [[Pulse oximetry]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]] (Cardiac enlargement, increased pulmonary vascular markings)


==2011 AASLD Recommendations for Acute Liver Failure (DO NOT EDIT) <ref name="urlwww.aasld.org">{{cite web |url=http://www.aasld.org/practiceguidelines/Documents/AcuteLiverFailureUpdate2011.pdf |title=www.aasld.org |format= |work= |accessdate=2012-10-26}}</ref>==
* [[Echocardiography]]
===General Measures (DO NOT EDIT)<ref name="urlwww.aasld.org">{{cite web |url=http://www.aasld.org/practiceguidelines/Documents/AcuteLiverFailureUpdate2011.pdf |title=www.aasld.org |format= |work= |accessdate=2012-10-26}}</ref>===
* [[MRI]]
* [[Cardiac catheterization]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Echocardiography]]
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Truncus arteriosus]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |sys/±dias
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
* [[CBC]]
* [[EKG]]
* [[Pulse oximetry]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]] (Cardiac enlargement, increased pulmonary vascular markings)


{| class="wikitable"
* [[Echocardiography]]
* [[MRI]]
* [[Cardiac catheterization]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Echocardiography]]
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
! rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |
! style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
! style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
! style="background:#4479BA; color: #FFFFFF;" align="center" |Central
! style="background:#4479BA; color: #FFFFFF;" align="center" |Dyspnea
! style="background:#4479BA; color: #FFFFFF;" align="center" |Fever
! style="background:#4479BA; color: #FFFFFF;" align="center" |Chest pain
! style="background:#4479BA; color: #FFFFFF;" align="center" |Clubbing
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral edema
! style="background:#4479BA; color: #FFFFFF;" align="center" |Auscultation
! style="background:#4479BA; color: #FFFFFF;" align="center" |Lab Findings
! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Heart failure]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
([[S3]])
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
* [[CBC]]
* Complete metabolic profile
* Cardiac enzymes
* BNP
* [[Thyroid function tests|Thyroid profile]]
* [[Renal function tests]]
* EKG
* [[Exercise stress testing|Exercise stress test]]
* [[ABG|ABG's]]
* [[Lipid profile]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* CXR
** Increase in heart size compared to the old film.
** Pleural fluid
** Interstitial edema
* Echocardiography
* Angiography
* Cardiac MRI
* Nuclear imaging
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Echocardiography]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Endomyocardial biopsy can be used when a specific diagnosis is suspected that would influence therapy in heart failure patients.
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Valvular heart disease]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CBC]]
* [[Complete metabolic profile]]
* [[Cardiac enzymes]]
* [[BNP]]
* [[Thyroid profile]]
* [[Renal function tests]]
* [[EKG]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]]
** To assess pulomary congestion or other lung pathology.
* [[Echocardiography]]
* [[Doppler echocardiography]]
* [[Angiography]]
** To assess the need for concomitant coronary artery bypass surgery in elderly people.
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Echocardiography]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Myocardial infarction]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CBC
* [[Complete metabolic profile
* [[Cardiac enzymes
* [[BNP]]
* [[Thyroid profile]]
* [[Renal function tests]]
* [[EKG]]
* [[Lipid profile]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]]
** Normal or may show signs of [[CHF]]
* [[Echocardiography]]
* [[Angiography]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
| style="text-align:center" | [[AASLD guidelines classification scheme#Classification of Recommendations|Class III]]
! colspan="2" rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Central Nervous system
! style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
! style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
! style="background:#4479BA; color: #FFFFFF;" align="center" |Central
! style="background:#4479BA; color: #FFFFFF;" align="center" |Dyspnea
! style="background:#4479BA; color: #FFFFFF;" align="center" |Fever
! style="background:#4479BA; color: #FFFFFF;" align="center" |Chest pain
! style="background:#4479BA; color: #FFFFFF;" align="center" |Clubbing
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral edema
! style="background:#4479BA; color: #FFFFFF;" align="center" |Auscultation
! style="background:#4479BA; color: #FFFFFF;" align="center" |Lab Findings
! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
|-
|-
| '''1.''' <nowiki>"</nowiki>Liver biopsy is recommended when autoimmune hepatitis is suspected as the cause of acute liver failure, and autoantibodies are negative.<nowiki>"</nowiki>
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Methemoglobinemia]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CBC]]
* [[Peripheral smear]]
* [[Complete metabolic profile]]
* [[Hemoglobin electrophoresis]]
* [[Serum nitrite levels]]
* [[Pulse oximetry]]
* [[ABG's]]
* [[Drug screen]]
* [[LDH]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]]
* [[EKG]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Family history of methemoglobinemia or glucose-6-phosphate dehydrogenase (G6PD) deficiency is important to determine.
|-
|-
| '''2.''' <nowiki>"</nowiki>In patients with acute liver failure who have a previous cancer history or massive hepatomegaly, consider underlying malignancy and obtain imaging and liver biopsy to confirm or exclude the diagnosis.<nowiki>"</nowiki>
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Polycythemia]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CBC]]
** Raised all cell lines in primary and only raised erythrocytes in secondary polycythemia
* [[Pulse oximetry]]
* [[Erythropoietin levels (EPO)]]
* [[Ferritin levels]]
* [[ABG's]]
* [[Increased leukocyte alkaline phosphatase]]
* [[B12 levels]]
* [[JAK 2 mutation]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[CXR]]
* [[EKG]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Tenderness in the sternum may indicate transformation to acute myeloid leukemia and should be properly investigated.
|-
|-
| '''3.''' <nowiki>"</nowiki>If the etiological diagnosis remains elusive after extensive initial evaluation, liver biopsy may be appropriate to attempt to identify a specific etiology that might influence treatment strategy.<nowiki>"</nowiki>
! style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
 
! style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
! style="background:#4479BA; color: #FFFFFF;" align="center" |Central
! style="background:#4479BA; color: #FFFFFF;" align="center" |Dyspnea
! style="background:#4479BA; color: #FFFFFF;" align="center" |Fever
! style="background:#4479BA; color: #FFFFFF;" align="center" |Chest pain
! style="background:#4479BA; color: #FFFFFF;" align="center" |Clubbing
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral edema
! style="background:#4479BA; color: #FFFFFF;" align="center" |Auscultation
! style="background:#4479BA; color: #FFFFFF;" align="center" |Lab Findings
! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Breath holding spells
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
{| class="wikitable"
|✔
|}
|}
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* No confirmatory study
* [[CBC]]
* [[Serum ferritin]]
* [[Blood lead level]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* video-EEG monitoring can be use in non diagnostic cases.
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Cyanotic breath-holding spells most commonly occur around 1 year of age with a range of six months to four years.
* Iron deficiency anemia is more prevalent in children with breath-holding spells. 
|-
! colspan="2" rowspan="3" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Miscellaneous
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Shock]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + (septic shock)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + (Cardiogenic shock)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Complete metabolic profile]]
* [[CBC]]
* [[Cardiac enzymes]]
* [[ABG's]]
* [[Lactate]]
* [[BNP]]
* [[Renal function tests]]
* [[Coagulation studies and D-dimer level]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Echocardiography]]
* [[Chest radiography]]
* [[Angiography]]
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Smoke inhalation
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*  [[CBC]]
[[Electrolytes]]


Acute liver failure is a serious condition which can rapidly progress to death if left untreated. Complications of the illness include [[cerebral edema]], [[brain herniation]], [[multi-organ failure]], [[systemic inflammatory response syndrome]], [[metabolic derangements]], [[coagulopathy]], [[hemodynamic instability]], [[coma]], and [[death]].Several prognostic scoring systems have been devised to predict mortality and to identify who will require early liver transplant. Mortality due to acute liver failure used to be as high as 80%, however this statistic has decreased with the advent of liver transplantation, and better intensive care. There are several prognostic indicator scores used for the prediction of mortality, and to assess the suitability of the patient for transplantation. These include [[King's College Criteria|kings college hospital criteria]], [[Model for End-Stage Liver Disease|MELD score]], [[APACHE II]] and Clichy criteria.
[[BUN and CR]],


[[Lactate levels]]


[[Toxicology screen]]


[[CO-oximetry]] 
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
** [[CXR]]
** [[ECG]]
** [[Serial cardiac enzymes]] (in patients with chest pain)\
** [[Pulmonary function testing]]
** [[Direct laryngoscopy and fiberoptic bronchoscopy]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* CO toxicity should be suspected in any patient who presents following smoke inhalation unless co-oximetry shows normal carboxyhemoglobin.
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Cold exposure
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Fingerstick glucose]] (Hyperglycemia)
*[[Electrocardiogram]] (ECG) may show J wave, sinus bradycardia and prolongation of all ECG intervals.


*[[Serum electrolytes]] (including potassium and calcium)


*[[BUN and creatinine]]


*[[Serum hemoglobin]], [[white blood cell]], and [[platelet]] counts ( Raised HCT due to volume contraction)


*[[Coagulation profile]] acidosis)


==Complications==
*[[Creatine kinase]] (Rhabdomylosis)
Complications that can develop as a result of acute liver failure are:
===Cerebral Edema and Encephalopathy===
* Complications of acute liver failure can include [[cerebral edema]] and [[hepatic encephalopathy]].
* The detection of encephalopathy is central to the diagnosis of acute liver failure. It may vary from subtle deficits in higher brain function (e.g. mood, concentration in grade I) to deep coma (grade IV).
* The patients presenting as acute and hyperacute liver failure are at greater risk of developing cerebral edema and grade IV encephalopathy.
* Cerebral edema in acute liver failure can be due to vasogenic and cytotoxic effects. The increased ammonia concentration in liver failure in combination with the glutamine produced by the astrocytes causes excess levels of glutamine with the help of enzyme glutamine synthetase. The excess glutamine is cytotoxic and can disturb the osmotic gradient which can result in brain swelling. In acute liver failure, the increased levels of nitric oxide in the circulation can also disrupt the cerebral autoregulation.<ref>{{cite journal |author=Hazell AS, Butterworth RF |title=Hepatic encephalopathy: An update of pathophysiologic mechanisms |journal=Proc. Soc. Exp. Biol. Med. |volume=222 |issue=2 |pages=99-112 |year=1999 |pmid=10564534 |doi=}}</ref><ref>{{cite journal |author=Larsen FS, Wendon J |title=Brain edema in liver failure: basic physiologic principles and management |journal=Liver Transpl. |volume=8 |issue=11 |pages=983-9 |year=2002 |pmid=12424710 |doi=10.1053/jlts.2002.35779}}</ref>.<ref>{{cite journal |author=Armstrong IR, Pollok A, Lee A |title=Complications of intracranial pressure monitoring in fulminant hepatic failure |journal=Lancet |volume=341 |issue=8846 |pages=690-1 |year=1993 |pmid=8095592 |doi=}}</ref> The aim is to maintain intracranial pressures below 25 mmHg, cerebral perfusion pressures above 50 mm Hg.
===Coagulopathy===
* [[Coagulopathy]] is also seen in acute liver failure. The liver has a central role in the synthesis of coagulation factors and some inhibitors of [[coagulation]] and [[fibrinolysis]].
* The hepatocyte [[necrosis]] leads to impaired [[synthesis]] of [[Coagulation|coagulation factors]] and their inhibitors. The former produces a prolongation in [[Prothrombin time]] which is widely used to monitor the severity of [[hepatic]] injury.
===Renal Failure===
[[Renal failure]] is common, present in more than 50% of acute liver failure patients, either due to original insult such as paracetamol resulting in [[acute tubular necrosis]] or from [[hyperdynamic circulation]] leading to [[hepatorenal syndrome]] or functional renal failure.
* Once the renal failure develops, it is progressive and poor prognosis without liver transplantation.
===Inflammation and Infection===
* About 60% of all acute liver failure patients fulfil the criteria for [[Systemic inflammatory response syndrome|systemic inflammatory syndrome]] irrespective of presence or absence of infection.<ref>{{cite journal |author=Schmidt LE, Larsen FS |title=Prognostic implications of [[Lactate|hyperlactatemia]], multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure |journal=Crit. Care Med. |volume=34 |issue=2 |pages=337-43 |year=2006 |pmid=16424712 |doi=}}</ref>. This often contributes towards [[Multiple organ dysfunction syndrome|multi organ failure]].
*The impaired host defence mechanisms due to impaired [[Opsonin|opsonisation]], [[chemotaxis]] and intracellular killing substantially increases the risk of sepsis. The sepsis is mostly due  [[Gram-positive bacteria|gram positive]] (80%)and fungal (30%) sepsis.<ref name="gimson">{{cite journal |author=Gimson AE |title=Fulminant and late onset hepatic failure |journal=British journal of anaesthesia |volume=77 |issue=1 |pages=90-8 |year=1996 |pmid=8703634 |doi=}}</ref>.
===Metabolic Derangements===
* The metabolic derrangements seen with acute liver failure include hyponatremia which is due to water retention and shift in [[intracellular]] sodium transport from inhibition of [[Na+/K+-ATPase|Na/K ATPase]].
* [[Hypoglycaemia]] due to depleted hepatic [[glycogen]] stores.
* [[Hypokalaemia]], [[hypophosphataemia]] and [[metabolic alkalosis]] are often present independent of renal function.
* [[Lactic acidosis]] is seen predominantly in paracetamol overdose. 
===Hemodynamic and Cardio-respiratory Compromise===
* [[Hyperdynamic circulation]] with peripheral [[vasodilator|vasodilatation]] from low [[systemic vascular resistance]] leads to [[hypotension]]. There is a compensatory increase in [[cardiac output]].
*  [[Adrenal insufficiency]] has been documented in 60% of acute liver failure and is likely to contribute in haemodynamic compromise<ref>{{cite journal |author=Harry R, Auzinger G, Wendon J |title=The clinical importance of adrenal insufficiency in acute hepatic dysfunction |journal=Hepatology |volume=36 |issue=2 |pages=395-402 |year=2002 |pmid=12143048 |doi=10.1053/jhep.2002.34514}}</ref>. There is also abnormal [[oxygen]] transport and utilization. Although delivery of oxygen to the tissues is adequate, there is a decrease in tissue oxygen uptake, resulting in [[tissue]] [[hypoxia]] and lactic acidosis<ref>{{cite journal |author=Bihari D, Gimson AE, Waterson M, Williams R |title=Tissue hypoxia during fulminant hepatic failure |journal=Crit. Care Med. |volume=13 |issue=12 |pages=1034-9 |year=1985 |pmid=3933911 |doi=}}</ref>.
* [[Pulmonary]] complication is also seen in acute liver failure.<ref>{{cite journal |author=Trewby PN, Warren R, Contini S, ''et al'' |title=Incidence and pathophysiology of pulmonary edema in fulminant hepatic failure |journal=Gastroenterology |volume=74 |issue=5 Pt 1 |pages=859-65 |year=1978 |pmid=346431 |doi=}}</ref>. Severe lung injury and [[hypoxemia]] result in high mortality. Most cases of severe lung injury is due to [[ARDS]] with or without[[ sepsis]]. Pulmonary [[haemorrhage]], [[pleural effusion]]s, [[atelectasis]], and intrapulmonary shunts also contribute to respiratory difficulty.


*[[Arterial blood gas]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* CXR
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* '''Mild hypothermia''': core temperature 32 to 35°C ; patient presents with confusion, tachycardia, and increased shivering.


*'''Moderate hypothermia''': 28 to 32°C  patient presents with lethargy, bradycardia and arrhythmia and decreased shivering.


*'''Severe hypothermia''': below 28°C patient presents with coma, hypotension, arrhythmia, pulmonary edema, and rigidity.
|-
|}
|}




Line 872: Line 2,059:




Acute liver failure is a sudden and severe loss of liver function with evidence of encephalopathy and coagulopathy with elevated prothrombin time (PT) and (INR) in a person without preexisting liver disease. The commonly used time duration for an acute liver disease is < 26 weeks.
* Acute liver failure can be hyperacute, acute or subacute depending upon how long the patient has signs and symptoms of liver failure.
* The natural history of acute liver failure depends on the etiology but generally, cerebral edema mainly presents in hyperacute or acute liver failure, whereas renal shutdown and portal hypertension are the main concerns in the subacute liver failure.
* If left untreated, patients with acute liver failure may initially have nonspecific symptoms such as anorexia, fatigue, nausea or vomiting, diffuse or right upper quadrant abdominal pain or jaundice and can eventually progress to develop confusion and the comatose state and death.


* The timely recognition and treatment of some of the causes of acute liver failure can reverse the condition and may improve the patient's prognosis. The timely evaluation can also help in identifying patients who may require liver transplantation.
* In acetaminophen toxicity patients, the time duration between acetaminophen ingestion and treatment with acetylcysteine greatly influence the outcome.






The evaluation of a patient diagnosed with acute liver failure should begin immediately to identify the cause of the acute liver failure. This is crucial because in some cases, early diagnosis and treatment may improve the patient's prognosis. In addition, timely evaluation is required to identify patients who may require urgent liver transplantation
Many of the initial symptoms in patients with acute liver failure are nonspecific [14]. They include:


●Fatigue/malaise
●Lethargy
●Anorexia
●Nausea and/or vomiting
●Right upper quadrant pain
●Pruritus
●Jaundice
●Abdominal distension from ascites
As the liver failure progresses, patients who were initially anicteric may develop jaundice, and those with subtle mental status changes (eg, lethargy, difficulty sleeping) may become confused or eventually comatose.


Acute liver failure refers to the development of severe acute liver injury with encephalopathy and impaired synthetic function (INR of ≥1.5) in a patient without cirrhosis or preexisting liver disease [2,3]. While the time course that differentiates acute liver failure from chronic liver failure varies between reports, a commonly used cutoff is an illness duration of <26 weeks.


Acute liver failure may also be diagnosed in patients with previously undiagnosed Wilson disease, vertically acquired hepatitis B virus, or autoimmune hepatitis, in whom underlying cirrhosis may be present, provided the disease has been recognized for <26 weeks. On the other hand, patients with acute severe alcoholic hepatitis, even if recognized for <26 weeks, are considered to have acute-on-chronic liver failure since most have a long history of heavy drinking. The approach to such patients is discussed elsewhere. (See "Clinical manifestations and diagnosis of alcoholic fatty liver disease and alcoholic cirrhosis" and "Prognosis and management of alcoholic fatty liver disease and alcoholic cirrhosis".)


Acute liver failure can be subcategorized based upon how long the patient has been ill and various cutoffs have been used. We classify acute liver failure as hyperacute (<7 days), acute (7 to 21 days), or subacute (>21 days and <26 weeks). In patients with hyperacute or acute liver failure, cerebral edema is common, whereas it is rare in subacute liver failure [4]. On the other hand, renal failure and portal hypertension are more frequently observed in patients with subacute liver failure. These subcategories have been associated with prognosis, but the associations reflect the underlying causes, which are the true determinants of prognosis. As an example, patients with hyperacute liver failure tend to have a better prognosis than those with subacute liver failure. The better prognosis is related to the fact that these patients often have acetaminophen toxicity or ischemic hepatopathy, diagnoses associated with a better prognosis than many of the disorders that may result in subacute liver failure, such as Wilson disease [2].
{| align="center"
|-
|
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
! colspan="3" rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Causes of cyanosis
! colspan="2" rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Cyanosis
| colspan="6" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Clinical manifestations/association'''
! colspan="3" rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Diagnosis
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Additional
findings
|-
| colspan="3" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Symptoms'''
! colspan="3" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Signs
|-
! style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral
! style="background:#4479BA; color: #FFFFFF;" align="center" |Central
! style="background:#4479BA; color: #FFFFFF;" align="center" |Dyspnea
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Fever
! style="background:#4479BA; color: #FFFFFF;" align="center" |Chest pain
! style="background:#4479BA; color: #FFFFFF;" align="center" |Clubbing
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Peripheral edema
! style="background:#4479BA; color: #FFFFFF;" align="center" |Auscultation
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Lab Findings
! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard
|-
! rowspan="14" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Respiratory
! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Airway
disorder
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Severe [[croup]]<ref name="Cherry2008">{{cite journal|last1=Cherry|first1=James D.|title=Croup|journal=New England Journal of Medicine|volume=358|issue=4|year=2008|pages=384–391|issn=0028-4793|doi=10.1056/NEJMcp072022}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Audible [[stridor]] at rest
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Lymphocytosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |AP Neck X ray for soft tissues:
* [[Steeple sign]]
Lateral neck X ray:
* Distended [[hypopharynx]] during [[inspiration]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Clinical diagnosis
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Croupy cough and [[stridor]]
* Intercostal, subcostal retractions
|-
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Epiglottitis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Stridor]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Leukocytosis]] with [[neutrophilia]]
* Blood cultures
* Throat culture in intubated patients  
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Lateral neck X ray
* [[Thumbprint sign]] (swollen epiglottis)
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Laryngoscopy]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Sore Throat]]
* [[Dysphagia]]
* [[Odynophagia]]
* Muffled voice
* Drooling
 
 






By definition, patients with acute liver failure have severe acute liver injury (demonstrated by liver test abnormalities) with signs of hepatic encephalopathy and a prolonged prothrombin time (INR ≥1.5). Other clinical manifestations may include jaundice, hepatomegaly, and right upper quadrant tenderness.


Symptoms — Many of the initial symptoms in patients with acute liver failure are nonspecific [14]. They include:


●Fatigue/malaise
●Lethargy
●Anorexia
●Nausea and/or vomiting
●Right upper quadrant pain
●Pruritus
●Jaundice
●Abdominal distension from ascites
As the liver failure progresses, patients who were initially anicteric may develop jaundice, and those with subtle mental status changes (eg, lethargy, difficulty sleeping) may become confused or eventually comatose.




Line 921: Line 2,151:




Acute liver failure results from the loss of normal function of hepatic tissue occurring over a short period of time. It results from the loss of the metabolic, secretory, and regulatory effects of the liver cells. This leads to the rapid accumulation of toxic substances, which then manifests in the patient as an altered [[sensorium]], [[cerebral edema]], [[hemodynamic]] abnormalities, and even [[multiorgan failure]].
Cytotoxic and vasogenic cerebral edema have been implicated in acute liver failure (ALF) with a preponderance of experimental data favouring cytotoxic mechanisms. Astrocyte swelling is a consistent neuropathological finding in human ALF and ammonia plays a definitive role. The mechanism(s) by which ammonia induces astrocyte swelling remains unclear but glutamine plays a central role inducing oxidative stress, energy failure and ultimately astrocyte swelling. Although complete breakdown of the blood-brain barrier is not evident in human ALF, increased permeation to water and ammonia has been demonstrated.




Cerebral edema in acute liver failure can be vasogenic as well as cytotoxic. The increased ammonia concentration in liver failure in combination with the glutamine produced by the astrocytes causes excess levels of glutamine synthesis with the help of glutamine synthetase. The excess glutamine is cytotoxic and can disturb the osmotic gradient and cause brain swelling. In acute liver failure, the increasesd levels of nitric oxide in the circulation can also disrupt the cerebral autoregulation.


[[Cerebral edema]] occurs due to damage to the [[blood brain barrier]] and can cause [[altered sensorium]] and [[increased intracranial pressure]]. Acute liver failure causes [[Hyperammonemia|increased ammonia concentrations]] due to the failure of the detoxification system that occurs through the liver. The increased levels of [[ammonia]] in combination with the [[glutamate]] produced by the [[astrocytes]] of brain, cause excess levels of glutamine produced through the enzyme [[glutamine synthetase]]. The accumulation of glutamine in high concentrations in the brain is what causes [[cerebral edema]].  In acute liver failure, there are also increased levels of nitric oxide in the circulation. Nitric oxide is a potent vasodilator and causes a disruption of the cerebral blood flow. This in turn disrupts [[cerebral auto-regulation]]. [[Multiorgan failure]] occurs due to severe [[hypotension]] which is caused by the decreased [[systemic vascular resistance]].






==Classification==
Acute liver failure may be classified on the basis of the duration of the [[symptoms]] between the onset of [[jaundice]] to the onset of [[encephalopathy]]. The different classification systems based on the number of weeks from the appearance of jaundice to the encephalopathy are:


{| class="wikitable"
! Classification system!! Duration
|-
|-
| O’Grady System||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Coma]]
* Hyperacute  (0 - 1 week)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
* Acute            ( From  2nd week - 4 weeks)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
* Subacute      ( From 4th week - 12 weeks)
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
| Bernuau System||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Seizure|Seizure<nowiki/>s]]
* Fulminant      ( 0 - 2 weeks) 
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
* Subfulminant  ( 2 weeks - 12 weeks)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
|Japanese System ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Head trauma
* Fulminant      (0 - 8 weeks)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
** Acute      ( 0 - 1.5 weeks)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
** Subacute ( 1.5 weeks - 8 weeks)
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
* Late-Onset    ( 8 weeks - 12 weeks)
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
|}
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
The 1993 classification defines three subcategories based on the severity and duration of the acute liver failure. <ref>O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. ''[[The Lancet|Lancet]] 1993;342:273-5. PMID 8101303.''</ref> The importance of this method of classification is that the pace of the disease evolution strongly influences prognosis. The underlying [[etiology]] causing the development of acute liver failure is the other significant determinant in regards to prognosis.<ref name="ogredy1">{{cite journal |author=O'Grady JG |title=Acute liver failure |journal=Postgraduate medical journal |volume=81 |issue=953 |pages=148-54 |year=2005 |pmid=15749789 |doi=10.1136/pgmj.2004.026005}}</ref> This classification system is based upon the duration between onset of [[jaundice]] to onset of [[encephalopathy]].
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
{| class="wikitable"
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! Classification!! Time
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
| Hyperacute|| 1 week
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Breath holding spells
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
| Acute|| 1 week - 1 month
! colspan="2" rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Miscellaneous
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Shock]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
! style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
|Subacute || 1 week - 3 months
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Smoke inhalation
|}
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
Acute liver failure can also be classified into fulminant or subfulminant. Both of these forms have a poor prognosis. It is based upon the duration between onset of hepatic illness, to the development of encephalopathy.<ref name="pmid9027947">{{cite journal |author=Williams R |title=Classification, etiology, and considerations of outcome in acute liver failure |journal=[[Seminars in Liver Disease]] |volume=16 |issue=4 |pages=343–8 |year=1996 |month=November |pmid=9027947 |doi=10.1055/s-2007-1007247 |url=http://www.thieme-connect.com/DOI/DOI?10.1055/s-2007-1007247 |accessdate=2012-10-26}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
{| class="wikitable"
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
! Classification !! Time
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
|Fulminant  || within 2 months
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Cold exposure
|-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |✔
|Subfulminant || within 2 months to 6 months
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
|}
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Complete blood count|CBC]]
*Fingerstick glucose (Hyperglycemia)
*EKG-
**J wave
**Sinus bradycardia
**Prolongation of all ECG intervals.


===O’Grady System===
*Serum electrolytes -K+ and calcium
The classification of encephalopathy according to the O’Grady system is as follows.<ref name="O'Grady-1993">{{Cite journal  | last1 = O'Grady | first1 = JG. | last2 = Schalm | first2 = SW. | last3 = Williams | first3 = R. | title = Acute liver failure: redefining the syndromes. | journal = Lancet | volume = 342 | issue = 8866 | pages = 273-5 | month = Jul | year = 1993 | doi =  | PMID = 8101303 }}</ref>


====Hyperacute====
*[[BUN]] and [[creatinine]]
Hyperacute encephalopathy is an encephalopathy that occurs within 7 days of onset of jaundice.


====Acute====
*[[PT]], [[PTT]]
Acute encephalopathy is an encephalopathy that occurs within an interval of 8 to 28 days from onset of jaundice.


====Subacute====
*S. [[lactate]]
Subacute encephalopathy is an encephalopathy that occurs within 5 to 12 weeks of onset of jaundice.


===Bernuau System===
*ABG
The classification of encephalopathy according to the Bernuau system is as follows.<ref name="Bernuau-1986">{{Cite journal  | last1 = Bernuau | first1 = J. | last2 = Rueff | first2 = B. | last3 = Benhamou | first3 = JP. | title = Fulminant and subfulminant liver failure: definitions and causes. | journal = Semin Liver Dis | volume = 6 | issue = 2 | pages = 97-106 | month = May | year = 1986 | doi = 10.1055/s-2008-1040593 | PMID = 3529410 }}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*'''Mild hypothermia''': core temperature 32 to 35°C ;
**[[Confusion]]
**[[Tachycardia]]
**Increased shivering.


====Fulminant====
*'''Moderate hypothermia''': 28 to 32°C
Fulminant encephalopathy is an encephalopathy that occurs within 2 weeks of onset of jaundice.
**[[Lethargy]]
**[[Bradycardia]]
**[[Arrhythmia]]
**Decreased shivering.


====Subfulminant====
*'''Severe hypothermia''': <28°C
Subfulminant encephalopathy is an encephalopathy that occurs within an interval of 2 to 12 weeks from onset of jaundice.
**[[Coma]]
**[[Hypotension]]
**[[Arrhythmias|Arrhythmia]]
**[[Pulmonary edema]]
**Rigidity
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Drugs†
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|}
|}


====Japanese System====
The classification of encephalopathy according to the Bernuau system is as follows.<ref name="Mochida-2008">{{Cite journal  | last1 = Mochida | first1 = S. | last2 = Nakayama | first2 = N. | last3 = Matsui | first3 = A. | last4 = Nagoshi | first4 = S. | last5 = Fujiwara | first5 = K. | title = Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis. | journal = Hepatol Res | volume = 38 | issue = 10 | pages = 970-9 | month = Oct | year = 2008 | doi = 10.1111/j.1872-034X.2008.00368.x | PMID = 18462374 }}</ref>


====Fulminant====
Fulminant encephalopathy is an encephalopathy that occurs within 8 weeks of onset of jaundice.


====Late-Onset====
Late onset encephalopathy is an encephalopathy that occurs within an interval of 8 to 24 weeks from onset of jaundice.


====Acute====
Acute encephalopathy is an encephalopathy that occurs within 10 days of onset of jaundice


====Subacute====
Subacute encephalopathy is an encephalopathy that occurs within an interval of 11 to 56 days from onset of jaundice
<references />
<references />

Latest revision as of 19:06, 13 June 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Differential diagnosis

span style="font-size:85%">Abbreviations: AP= Anteroposterior, CXR= Chest X-ray, CT= Computed tomography, ABG= Arterial blood gas, V/Q= Ventilation/perfusion scan , EKG= Electrocardiogram, COPD= Chronic obstructive pulmonary disease, BNP= Brain natriuretic peptide, DVT= Deep vein thrombosis, HRCT= High Resolution CT, IgE= Immunoglobulin E

Causes of cyanosis Disease Cyanosis Clinical manifestations/association Diagnosis Additional

findings

Symptoms Signs
Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard
Respiratory Airway

disorder

Severe croup[1] Audible stridor at rest AP Neck X ray for soft tissues:

Lateral neck X ray:

  • Croupy cough and stridor
  • Intercostal, subcostal retractions
Epiglottitis Stridor Lateral neck X ray

Abbreviations: AP= Anteroposterior, CXR= Chest X-ray, CT= Computed tomography, ABG= Arterial blood gas, V/Q= Ventilation/perfusion scan , EKG= Electrocardiogram, COPD= Chronic obstructive pulmonary disease, BNP= Brain natriuretic peptide, DVT= Deep vein thrombosis, HRCT= High Resolution CT, IgE= Immunoglobulin E

Causes of cyanosis Disease Cyanosis Clinical manifestations/association Diagnosis Additional

findings

Symptoms Signs
Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard
Respiratory Airway

disorder

Severe croup[1] Audible stridor at rest AP Neck X ray for soft tissues:

Lateral neck X ray:

  • Croupy cough and stridor
  • Intercostal, subcostal retractions
Epiglottitis Stridor Lateral neck X ray
Foreign body aspiration CXR

CT scan

Complications:
Bacterial tracheitis Lateral neck X ray
  • Brassy cough
  • Retractions
  • No drooling
  • Hoarseness
Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings
Parenchymal

disorder

Pneumonia
  • CXR
  • CT chest
  • Bronchoscopy
  • Sputum culture and gram stain
  • Blood cultures
  • Urine antigen
Asthma

(Late)

✔ in interstitial lung disease
  • End expiratory wheeze
  • Absent wheeze and breath sounds in severe form
CXR
  • to rule out other diagnosis
  • complications like pneumonia, atelactasis

HRCT

Cystic fibrosis when infected Wheeze or crackles CXR

HRCT for detecting lung changes

  • Sweat test
COPD

(Severe emphysema)

  • Reduced breath sounds
  • Prolonged expiration
  • Wheeze
  • Inspiratory crackles
CXR
  • Elongated heart
  • Flattening of diaphragms
  • Prominent hilar vasculature

HRCT

  • Bullae
  • HRCT
Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings
Pulmonary vascular disorders Massive pulmonary embolism
  • Reduced breath sounds
  • Rales, crackles
  • Loud P2
Pulmonary arterio-venous malformation[2][3][4]
  • Pulmonary bruit
CXR
  • Round/oval mass
    • lobulated
    • well defined
  • Connecting vessel in hilum
  • Hemothorax
Chest
wall disorders
Flail chest
Cardiovascular Pneumothorax
Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings

Atrioventricular canal defect

+ ± +
  • CXR (Cardiac enlargement, Increased pulmonary vascular markings)
Ebstein anomaly + ± +
  • CXR (Cardiac enlargement, decreased pulmonary vascular markings)
Tetralogy of Fallot + ± + (systolic)
  • CXR (Boot shaped heart, decreased pulmonary vascular markings)
Pulmonic stenosis + ± + (systolic)
  • CXR (Cardiac enlargement, decreased pulmonary vascular markings)
Total anomalous pulmonary venous connection + ± + (Systolic)
  • CXR (normal heart size and venous congestion but in patients without obstruction have cardiomegaly and increased pulmonary blood flow.)
Transposition of the great vessels + ± -
  • CXR (Cardiac enlargement, increased pulmonary vascular markings)
Truncus arteriosus + ± sys/±dias
  • CXR (Cardiac enlargement, increased pulmonary vascular markings)
Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings
Heart failure + + + +

(S3)

  • CXR
    • Increase in heart size compared to the old film.
    • Pleural fluid
    • Interstitial edema
  • Echocardiography
  • Angiography
  • Cardiac MRI
  • Nuclear imaging
  • Endomyocardial biopsy can be used when a specific diagnosis is suspected that would influence therapy in heart failure patients.
Valvular heart disease ± + +
Myocardial infarction + + +
Central Nervous system Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings
Methemoglobinemia + + + Family history of methemoglobinemia or glucose-6-phosphate dehydrogenase (G6PD) deficiency is important to determine.
Polycythemia + + Tenderness in the sternum may indicate transformation to acute myeloid leukemia and should be properly investigated.
Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings
Breath holding spells
  • video-EEG monitoring can be use in non diagnostic cases.
  • Cyanotic breath-holding spells most commonly occur around 1 year of age with a range of six months to four years.
  • Iron deficiency anemia is more prevalent in children with breath-holding spells. 
Miscellaneous Shock + + (septic shock) + + (Cardiogenic shock)
Smoke inhalation + + +

Electrolytes

BUN and CR,

Lactate levels

Toxicology screen

CO-oximetry 

  • CO toxicity should be suspected in any patient who presents following smoke inhalation unless co-oximetry shows normal carboxyhemoglobin.
Cold exposure
  • CXR
  • Mild hypothermia: core temperature 32 to 35°C ; patient presents with confusion, tachycardia, and increased shivering.
  • Moderate hypothermia: 28 to 32°C patient presents with lethargy, bradycardia and arrhythmia and decreased shivering.
  • Severe hypothermia: below 28°C patient presents with coma, hypotension, arrhythmia, pulmonary edema, and rigidity.








Causes of cyanosis Cyanosis Clinical manifestations/association Diagnosis Additional

findings

Symptoms Signs
Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard
Respiratory Airway

disorder

Severe croup[5] Audible stridor at rest AP Neck X ray for soft tissues:

Lateral neck X ray:

Clinical diagnosis
  • Croupy cough and stridor
  • Intercostal, subcostal retractions
Epiglottitis Stridor Lateral neck X ray










Coma
Seizures
Head trauma
Breath holding spells
Miscellaneous Shock
Smoke inhalation + + +
Cold exposure
  • CBC
  • Fingerstick glucose (Hyperglycemia)
  • EKG-
    • J wave
    • Sinus bradycardia
    • Prolongation of all ECG intervals.
  • Serum electrolytes -K+ and calcium
  • ABG
Drugs†



  1. 1.0 1.1 Cherry, James D. (2008). "Croup". New England Journal of Medicine. 358 (4): 384–391. doi:10.1056/NEJMcp072022. ISSN 0028-4793.
  2. Khurshid I, Downie GH (2002). "Pulmonary arteriovenous malformation". Postgrad Med J. 78 (918): 191–7. PMC 1742331. PMID 11930021.
  3. Doshi HM, Robinson S, Chalhoub T, Jack S, Denison A, Gibson G (2009). "Massive spontaneous hemothorax during the immediate postpartum period". Tex Heart Inst J. 36 (3): 247–9. PMC 2696501. PMID 19568398.
  4. Chanatry BJ (1992). "Acute hemothorax owing to pulmonary arteriovenous malformation in pregnancy". Anesth. Analg. 74 (4): 613–5. PMID 1554132.
  5. Cherry, James D. (2008). "Croup". New England Journal of Medicine. 358 (4): 384–391. doi:10.1056/NEJMcp072022. ISSN 0028-4793.

Differential diagnosis

Abbreviations: AP= Anteroposterior, CXR= Chest X-ray, CT= Computed tomography, ABG= Arterial blood gas, V/Q= Ventilation/perfusion scan , EKG= Electrocardiogram, COPD= Chronic obstructive pulmonary disease, BNP= Brain natriuretic peptide, DVT= Deep vein thrombosis, HRCT= High Resolution CT, IgE= Immunoglobulin E

Causes of cyanosis Disease Cyanosis Clinical manifestations/association Diagnosis Additional

findings

Symptoms Signs
Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard
Respiratory Airway

disorder

Severe croup[1] Audible stridor at rest AP Neck X ray for soft tissues:

Lateral neck X ray:

  • Croupy cough and stridor
  • Intercostal, subcostal retractions
Epiglottitis Stridor Lateral neck X ray
Foreign body aspiration CXR

CT scan

Complications:
Bacterial tracheitis Lateral neck X ray
  • Brassy cough
  • Retractions
  • No drooling
  • Hoarseness
Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings
Parenchymal

disorder

Pneumonia
  • CXR
  • CT chest
  • Bronchoscopy
  • Sputum culture and gram stain
  • Blood cultures
  • Urine antigen
Asthma

(Late)

✔ in interstitial lung disease
  • End expiratory wheeze
  • Absent wheeze and breath sounds in severe form
CXR
  • to rule out other diagnosis
  • complications like pneumonia, atelactasis

HRCT

Cystic fibrosis when infected Wheeze or crackles CXR

HRCT for detecting lung changes

  • Sweat test
COPD

(Severe emphysema)

  • Reduced breath sounds
  • Prolonged expiration
  • Wheeze
  • Inspiratory crackles
CXR
  • Elongated heart
  • Flattening of diaphragms
  • Prominent hilar vasculature

HRCT

  • Bullae
  • HRCT
Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings
Pulmonary vascular disorders Massive pulmonary embolism
  • Reduced breath sounds
  • Rales, crackles
  • Loud P2
Pulmonary arterio-venous malformation[2][3][4]
  • Pulmonary bruit
CXR
  • Round/oval mass
    • lobulated
    • well defined
  • Connecting vessel in hilum
  • Hemothorax
Chest
wall disorders
Flail chest
Cardiovascular Pneumothorax
Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings

Atrioventricular canal defect

+ ± +
  • CXR (Cardiac enlargement, Increased pulmonary vascular markings)
Ebstein anomaly + ± +
  • CXR (Cardiac enlargement, decreased pulmonary vascular markings)
Tetralogy of Fallot + ± + (systolic)
  • CXR (Boot shaped heart, decreased pulmonary vascular markings)
Pulmonic stenosis + ± + (systolic)
  • CXR (Cardiac enlargement, decreased pulmonary vascular markings)
Total anomalous pulmonary venous connection + ± + (Systolic)
  • CXR (normal heart size and venous congestion but in patients without obstruction have cardiomegaly and increased pulmonary blood flow.)
Transposition of the great vessels + ± -
  • CXR (Cardiac enlargement, increased pulmonary vascular markings)
Truncus arteriosus + ± sys/±dias
  • CXR (Cardiac enlargement, increased pulmonary vascular markings)
Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings
Heart failure + + + +

(S3)

  • CXR
    • Increase in heart size compared to the old film.
    • Pleural fluid
    • Interstitial edema
  • Echocardiography
  • Angiography
  • Cardiac MRI
  • Nuclear imaging
  • Endomyocardial biopsy can be used when a specific diagnosis is suspected that would influence therapy in heart failure patients.
Valvular heart disease ± + +
Myocardial infarction + + +
Central Nervous system Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings
Methemoglobinemia + + + Family history of methemoglobinemia or glucose-6-phosphate dehydrogenase (G6PD) deficiency is important to determine.
Polycythemia + + Tenderness in the sternum may indicate transformation to acute myeloid leukemia and should be properly investigated.
Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings
Breath holding spells
  • video-EEG monitoring can be use in non diagnostic cases.
  • Cyanotic breath-holding spells most commonly occur around 1 year of age with a range of six months to four years.
  • Iron deficiency anemia is more prevalent in children with breath-holding spells. 
Miscellaneous Shock + + (septic shock) + + (Cardiogenic shock)
Smoke inhalation + + +

Electrolytes

BUN and CR,

Lactate levels

Toxicology screen

CO-oximetry 

  • CO toxicity should be suspected in any patient who presents following smoke inhalation unless co-oximetry shows normal carboxyhemoglobin.
Cold exposure
  • CXR
  • Mild hypothermia: core temperature 32 to 35°C ; patient presents with confusion, tachycardia, and increased shivering.
  • Moderate hypothermia: 28 to 32°C patient presents with lethargy, bradycardia and arrhythmia and decreased shivering.
  • Severe hypothermia: below 28°C patient presents with coma, hypotension, arrhythmia, pulmonary edema, and rigidity.








Causes of cyanosis Cyanosis Clinical manifestations/association Diagnosis Additional

findings

Symptoms Signs
Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard
Respiratory Airway

disorder

Severe croup[5] Audible stridor at rest AP Neck X ray for soft tissues:

Lateral neck X ray:

Clinical diagnosis
  • Croupy cough and stridor
  • Intercostal, subcostal retractions
Epiglottitis Stridor Lateral neck X ray










Coma
Seizures
Head trauma
Breath holding spells
Miscellaneous Shock
Smoke inhalation + + +
Cold exposure
  • CBC
  • Fingerstick glucose (Hyperglycemia)
  • EKG-
    • J wave
    • Sinus bradycardia
    • Prolongation of all ECG intervals.
  • Serum electrolytes -K+ and calcium
  • ABG
Drugs†



  1. Cherry, James D. (2008). "Croup". New England Journal of Medicine. 358 (4): 384–391. doi:10.1056/NEJMcp072022. ISSN 0028-4793.
  2. Khurshid I, Downie GH (2002). "Pulmonary arteriovenous malformation". Postgrad Med J. 78 (918): 191–7. PMC 1742331. PMID 11930021.
  3. Doshi HM, Robinson S, Chalhoub T, Jack S, Denison A, Gibson G (2009). "Massive spontaneous hemothorax during the immediate postpartum period". Tex Heart Inst J. 36 (3): 247–9. PMC 2696501. PMID 19568398.
  4. Chanatry BJ (1992). "Acute hemothorax owing to pulmonary arteriovenous malformation in pregnancy". Anesth. Analg. 74 (4): 613–5. PMID 1554132.
  5. Cherry, James D. (2008). "Croup". New England Journal of Medicine. 358 (4): 384–391. doi:10.1056/NEJMcp072022. ISSN 0028-4793.